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Zusammenfassung  
Afrikanische Trypanosomen sind begeißelte Protozoenparasiten, welche die Schlafkrankheit 
beim Menschen und die Nagana-Seuche bei Rindern verursachen. Während ihres 
Lebenszyklus verändern sie sowohl ihre Morphologie als auch ihren Metabolismus mittels 
ausgeprägter genregulatorischer Mechanismen. Trypanosomen sind gekennzeichnet durch 
die einzigarte, polycistronische Anordnung ihrer Gene und müssen daher fast ausschließlich 
auf post-transkriptionelle Regulationsmechanismen zurückgreifen, um die Genexpression zu 
regulieren, was Verarbeitung, Export, Stabilität und Translation der mRNA umfasst. Daran 
sind RNA-bindende Proteine wie auch Translationsfaktoren beteiligt. Trypanosomen haben 
sechs eIF4Es mit unterschiedlichen Affinitäten für die mRNA-Kappe und fünf eIF4Gs, welche 
vielerlei Möglichkeiten für die Translationsregulation darbieten. TbEIF4E1 interagiert mit 
keinem der eIF4Gs, sondern stattdessen mit einem 4E-interagierenden Protein, 4EIP, auf 
welchem der Focus des ersten Teils dieser Thesis liegt. Sowohl TbEIF4E1 als auch Tb4EIP 
reprimieren die Expression einer Reporter-mRNA, wenn sie artifiziell an diese gebunden sind 
(„Tethering Assay“), jedoch braucht die Inhibition durch TbEIF4E1 Tb4EIP. Blutstrom-Formen 
von Trypanosoma brucei, welchen Tb4EIP fehlt, zeigen nur einen geringen 
Wachstumsnachteil. Bei hoher Parasitämie hören die Blutstrom-Formen auf sich zu teilen, 
unterdrücken die Translation und werden zu Stumpy-Formen, welche an die Differenzierung 
zu prozyklischen Formen angepasst sind, sobald sie von einer Tsetsefliege aufgenommen 
werden. Interessanterweise beeinträchtigt das Fehlen von Tb4EIP die Entwicklung zur 
Stumpy-Form, und dieser Effekt kann durch eine verkürzte Version von 4EIP gerettet werden, 
welche nicht an TbEF4E1 binden kann. Stumpy-Formen der Tb4EIP-defizienten Zellen haben 
ungewöhnlich hohe Protein-Syntheseraten, was darauf hindeutet, dass Tb4EIP für die 
Unterdrückung der Translation während der Differenzierung zu Stumpy-Formen benötigt wird. 
Das RNA-bindende Protein PUF3 gehört zu den 11 T. brucei Proteinen mit einer Pumilio-
Domäne. Bisher war wenig über PUF3 bekannt, außer dass es die Translation einer Reporter-
mRNA unterdrücken kann und dass es zusammen mit Poly(A)-mRNA aufgereinigt werden 
kann. Daher liegt auf diesem der zweite Schwerpunkt meiner Thesis. Monomorphe und 
pleomorphe Blutstrom-Formen, in welchen die Menge an PUF3 erheblich vermindert wurde, 
haben einen sehr geringfügigen Wachstumsdefekt, jedoch zeigen Zellen mit einem PUF3 
Gen-Knockout diesen Defekt seltsamerweise nicht. Bei Verwendung der PUF3-depletierten 
Zellen für Differenzierungsexperimente zu Stumpy-Formen oder prozyklischen Formen, haben 
diese Zellen interessanterweise eine Verzögerung bei diesen Differenzierungsprozessen 
gezeigt, was mit einer geringen Expression des Stumpy-Form Markerproteins PAD1 bzw. der 
prozyklischen Oberflächenproteine EP/GPEET einherging. Nichtsdestotrotz sind die Zellen 
letztendlich zu prozyklischen Formen differenziert. Interessanterweise haben sich die 
Blutstrom-Formen ohne PUF3 zu einem späteren Zeitpunkt angepasst und haben diesen 
Differenzierungsdefekt nicht gezeigt. Allerdings persistierte dieser Defekt in monomorphen 
Zellen, was einen Anpassungsmechanismus in pleomorphen Zellen nahelegt, welcher den 
zellulären Metabolismus angleicht an ein Leben ohne PUF3. Mittels der TRIBE (Targets of 
RNA binding proteins Identified by Editing) Methode wurden 295 mutmaßliche Ziel-mRNAs 
von PUF3 in Stumpy-Formen identifiziert. 79 dieser Ziel-mRNAs stammen von Genen, welche 
vorzugsweise in Blutstrom-Formen exprimiert werden, was mit einer Rolle für PUF3 als 
Repressor übereinstimmt. Diese umfassen mRNAs, welche für Zytoskelett-Proteine kodieren, 
sowie Proteinkinasen, RNA-bindende Proteine, Proteine mit Leucin-reichen repetitiven 
Sequenzen, sogenannte Expression-Site Associated Genes, Chaperone und 
Translationsfaktoren. Die dargestellten Ergebnisse deuten darauf hin, dass Tb4EIP und PUF3 
bei der Feinabstimmung von mRNA-Mengen in Vorbereitung auf die Differenzierung wichtig 
sind.
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Summary 
African trypanosomes are flagellated protozoan parasites that cause sleeping sickness in 
humans and nagana in cattle. During their life cycle, they change their morphology and 
metabolism through robust gene regulation processes. Trypanosomes have a unique 
polycistronic gene arrangement and have to rely almost entirely on post-transcriptional 
regulation mechanisms, which include mRNA processing, export, stability and translation, in 
order to regulate gene expression. RNA binding proteins and translation factors are involved. 
Trypanosomes have six eIF4Es of varying cap-binding affinities and five eIF4Gs, suggesting 
numerous possibilities for translation regulation. TbEIF4E1 does not interact with any of the 
eIF4Gs but instead interacts with 4E-interacting protein, 4EIP, which is the first focus of this 
thesis. Both TbEIF4E1 and Tb4EIP repress a reporter mRNA in a tethering assay, but 
suppression by TbEIF4E1 requires Tb4EIP. Bloodstream form Trypanosoma brucei lacking 
Tb4EIP have only a mild growth defect. At high parasitemia, bloodstream forms stop dividing, 
suppress translation and become stumpy forms, which are adapted to differentiate to procyclic 
forms when taken up by a tsetse fly. Interestingly, lack of Tb4EIP compromises stumpy 
formation, and the defect can be rescued by a truncated Tb4EIP that is unable to bind 
TbEIF4E1. Tb4EIP knockout stumpy forms have abnormally high protein synthesis rates 
indicating that Tb4EIP is required for translation suppression during differentiation to the 
stumpy form. 
RNA binding protein PUF3 is among 11 T. brucei pumilio domain containing proteins. Little 
was known about PUF3 save for its repression of a reporter mRNA and that it co-purifies with 
poly(A) mRNA. It is therefore the second focus of this thesis. PUF3-depleted monomorphic 
and pleomorphic bloodstream cells have a marginal growth defect but PUF3 knockout cells 
strangely lack this defect. Interestingly, when put to differentiate to stumpy and procyclic 
forms, PUF3-depleted pleomorphic bloodstream cells experience a delayed differentiation 
manifested by a low expression of the stumpy form marker PAD1 and procyclic surface coat 
proteins EP/GPEET. Nevertheless these cells eventually differentiated to viable procyclic 
forms. Surprisingly, pleomorphic bloodstream cells without PUF3 later seemed to adapt and 
lack this differentiation defect. The defect however persists in monomorphic cells, suggesting 
an adaptation mechanism in pleomorphic cells that equilibrates the cellular metabolism to life 
without PUF3. Using TRIBE (Targets of RNA binding proteins Identified by Editing) 295 
putative targets of PUF3 were identified in stumpy-like cells. 79 of these targets are enriched 
in bloodstream forms while only 12 are enriched in procyclic forms, consistent with a role of 
PUF3 as a repressor during differentiation to procyclic forms. These targets include mRNAs 
encoding cytoskeleton proteins, protein kinases, RNA binding proteins, leucine rich repeat 
proteins, expression-site associated genes, chaperones and translation factors. The results 
here suggest that Tb4EIP and PUF3 fine-tune gene expression in readiness for differentiation. 
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1.0 Introduction 
1.1 Background 
Trypanosomes are flagellated protozoan parasites that belong to the class Kinetoplastida. 
Kinetoplastids have a characteristic organelle called kinetoplast at the base of the flagellum, 
which contains mitochondrial DNA. They are also known for compartmentalizing glycolytic 
enzymes in a microbody-like organelle called the glycosome, instead of in the cytosol 1, and 
trans-splicing of a 39 nucleotide long sequence called the spliced leader on to all mRNAs 2,3 . 
Members of Kinetoplastida include free-living organisms and parasites of plants and animals. 
The family Bodonidae and Cryptobiidae have two flagella and consists mostly of free-living 
aquatic species exemplified by Bodo species, with a few parasites e.g. the fish parasite 
Cryptobia salmositica. The family Trypanosomatidae consists of uni-flagellated parasites of 
plants, ciliates, vertebrates and invertebrates 4. The genus Phytomonas infects plants but 
causes disease in only few plants including oil palm, coconut and coffee trees 5. Other two 
genera of medical and veterinary importance are Trypanosoma and Leishmania. 
Trypanosoma brucei cause human and animal African trypanosomiasis and are transmitted by 
Glossina spp (Tsetse fly), whereas T. cruzi cause Chagas disease (also known as American 
trypanosomiasis) and are transmitted by Triatominae bugs. Leishmania species cause 
visceral, cutaneous or muco-cutaneous leishmaniasis and are transmitted by Phlebotomus 
and Lutzomyia spp (Sand fly). 
 
1.2 Diseases caused by African trypanosomes 
Trypanosoma brucei rhodesiense and T.b. gambiense cause Human African trypanosomiasis 
(HAT), also known as sleeping sickness, and are responsible for 3% and 97% of HAT 
morbidities respectively 6. HAT is characterized by two stages 7. In the early stage, parasites 
multiply in the skin, blood and lymph causing non-specific signs and symptoms such as 
itchiness, headaches and joint pains. The second or late stage occurs when the parasite 
crosses the blood-brain barrier and manifests with more obvious symptoms like altered 
sleeping cycle, sensory disorders, visual impairment and motor weakness. If not treated the 
patient progresses into coma and death 7,8. 
T.b. rhodesiense is found in eastern and southern Africa and it causes an acute form of the 
disease, which enters the late stage within a few weeks or months. Suramin and melarsoprol 
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are used to treat the early and late stages, respectively, of the T.b. rhodesiense HAT 8,9. T.b. 
gambiense causes a chronic form of HAT whose symptoms manifest more slowly. The early 
stage of T.b. gambiense HAT is treated with pentamidine whereas the late stage is treated 
with melarsoprol or nifurtimox-eflornithine combination therapy (NECT) 8,10,11. 
The burden of treatment is in the toxicity of the drugs, the large amounts required per dose 
and the long period of administration that requires a health centre and specialists 7,12. 
Melarsoprol, for example, causes encephalopathy in 10% of patients, which is lethal in 50% of 
such cases 7,8,13. Despite the challenges in diagnosis and treatment, surveillance and control 
programs have contributed to a decrease in new reported cases to 3,797, the lowest since 
2010 6. 
Animal African trypanosomiasis (AAT) is mainly caused by Trypanosoma congolense and 
Trypanosoma vivax. Other species that cause nagana and similar diseases include T.b. brucei 
and T. simiae; they infect domestic (cattle, pigs, sheep, goat, camels and dogs) and wild 
animals 14,15. T. evansi is also found in Asia, central and southern America and it causes Surra 
in camels, horses, buffalos, elephants and dogs. Its transmission is mechanical as it lacks the 
kinetoplast maxicircle DNA, which encodes mitochondrial proteins required for survival in the 
tsetse fly host 16. T. equiperdum causes dourine in horses and donkeys worldwide, and is 
sexually transmitted 17. AAT is treated mainly using homidium bromide and chloride, 
isometamidium and diminazene aceturate. These are very old drugs with high toxicity and 
have a huge problem of resistance 15. 
Collectively, with infected and affected humans unable to work, and their infected animals 
unproductive in both food production and horse power, the socio-economic impact of African 
tryanosomiasis and tsetse flies is enormous; Food and Agriculture Organization (FAO) 
estimates that the combined impact of HAT and AAT in terms of gross domestic product is a 
loss of approximately $4.7 billion per annum 
(http://www.fao.org/ag/againfo/programmes/en/paat/disease.html). In the spirit of finding better 
treatments and disease control mechanisms, great advances have been made over a century 
on trypanosome cell biology and have led to discoveries like antigenic variation and trans-
splicing which have broad applications. Trypanosomes are also genetically amenable and 
have become a model in studying aspects in parasitology and cell biology.  
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1.3 Life cycle of T. brucei and in vitro differentiation 
The life cycle of T. brucei involves the cyclical transmission between mammals and tsetse flies 
and is summarized in Figure 1. In the mammal, T. brucei divide as long slender forms in the 
blood and other tissue fluids and are referred to as bloodstream forms. They have a 
rudimentary mitochondrion and utilize substrate-level phosphorylation for ATP production in a 
specialized microbody called the glycosome, which compartmentalizes the first seven 
glycolytic enzymes 1,18. 
 
Figure 1: Life cycle of Trypanosoma brucei. Surface proteins are shown in different colour 
shades. Blue text and arrows indicate in vitro introduced manipulations that mimic the natural 
course of the life cycle. SIF – stumpy induction factor. The image was made by Christine 
Clayton and it includes minor modifications. 
Bloodstream forms have a dense GPI-anchored coat of variant surface glycoproteins (VSGs). 
Its periodic replacement with a new variant enables the parasites evade the host immune 
machinery, a phenomenon called antigenic variation 19–21. As the host immune catches up with 
the parasites, a sub-population that has switched to expressing a new VSG can survive, thus 
creating rising and falling waves of parasitemia. It is known that trypanosomes have up to 
2000 VSG genes and gene fragments, and only one VSG is expressed at a time, guaranteed 
by an enigmatic allelic exclusion mechanism 21. With this repertoire of genes and antigenic 
variation, the parasite is always steps ahead of the host immune and vaccination against 
trypanosomes is probably impossible. 
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At peak parasitemia, the long slender forms respond to a stumpy induction factor (SIF) in a 
density dependent mechanism, become arrested at G1/G0 phase, and differentiate into cells 
with short-stumpy morphology 22–25. It is thought that this growth arrest ensures that 
cytological repositioning events that accompany differentiation are not interfered with by those 
accompanying cell division 25. Stumpy forms have reduced translation but express some new 
proteins including some mitochondrial proteins, are tolerant to low pH and proteolysis and are 
thus pre-adapted to differentiate further once in the insect midgut 23,26. In addition, they 
express carboxylate transporters called PAD (proteins associated with differentiation), which 
convey the differentiation signal cis-aconitate. PAD1 in particular is specifically expressed in 
stumpy forms and is thus a convenient stumpy marker 27. PAD2 is expressed in response to 
cold 27, whereas PAD4, 6 and 8 seem to be expressed in epimastigotes 28. The roles of most 
PAD proteins is still unclear. 
To prevent premature differentiation to stumpy forms, a tyrosine phosphatase TbPTP1 in 
slender forms phosphorylates and inhibits the DxDxDx serine threonine phosphatase, 
TbPIP39 (PTP1 interacting protein, 39kDa). During differentiation, TbPTP1 is inhibited, and 
TbPIP39 is dephosphorylated, localized to the glycosomes and stumpy formation is initiated 
29. The targets of TbPIP39 in the cascade are still unknown. 
Apart from becoming stumpy in shape, another cytological rearrangement that occurs during 
stumpy formation is relocation of the lysosome. In slender forms, the lysosome is 
approximately equidistant between the kinetoplast and the nucleus. As they become stumpy, 
it relocates from the posterior to the anterior of the nucleus producing the relatively short 
distance between the nucleus and kinetoplast characteristic of stumpy forms 25,30. 
In culture, slender to stumpy differentiation is achieved by growing slender cells to peak 
densities in viscous HMI-9 media containing 1.1% methyl cellulose 31,32. Alternatively, slender 
cells can be grown in the presence of hydrolysable cAMP analogs that induce stumpy 
formation 33–35. These compounds however generate unhealthy cells lacking a fully stumpy 
morphology 35. Disruption of the active VSG expression sites can also induce stumpy 
formation 36. 
During a blood meal from an infected mammal, the fly ingests the stumpy forms along with the 
blood. The stumpy forms develop a functional mitochondrion, the kinetoplast repositions to a 
position midway between the posterior edge and the nucleus, and they change their VSG coat 
to GPEET and EP procyclins to become procyclic forms. GPEET is highly phosphorylated 
while EP is highly glycosylated making both proteins appear like a smear in Western blots. 
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Dividing procyclic forms utilize amino acids (mainly proline) as their main carbon source, and 
oxidative phosphorylation for ATP production 37. Usually not all flies get infected after a blood 
meal; by the fifth day, fly infections fall into either non-detectable or heavy infection, partly due 
to the fly’s immune barriers 38. GPEET is repressed after day six and this time coincides with 
the crossing of the procyclic forms into the ectoperitrophic space, implicating GPEET in a 
specific function while the parasites are still within the bloodmeal 39,40. 
In culture conditions, differentiation to procyclic forms is induced by treatment of stumpy cells 
with 6mM cis-aconitate and reduction in temperature from 37°C to 27°C 41. Alternatively, long 
slender forms can directly but less efficiently be transformed to procyclic forms using the same 
treatment 42. GPEET expression in vitro is maintained by addition of glycerol in the growing 
media and its mRNA is regulated by the action of mitochondrial enzymes, glycerol and 
hypoxia 39,43 in addition to the action of RNA binding proteins 44. Differentiation can 
conveniently be followed by monitoring the expression of GPEET or EP procyclin 32,45. By 
immunofluorescence, the repositioning of the kinetoplast to a midpoint position between the 
nucleus and the posterior edge can also be used to identify procyclic forms. 
Depending on their ability to differentiate to stumpy forms, cells are described as either 
monomorphic or pleomorphic. Monomorphic cells are laboratory-adapted strains that are 
incapable of differentiating to stumpy forms. They can differentiate to procyclic forms but these 
cannot divide and eventually die. Monomorphics can however grow to high densities in 
bloodstream-form cultures and are routinely used in most experiments. An example is the 
Lister 427 strain. In contrast, pleomorphic forms can differentiate to stumpy forms and can 
complete the life cycle in tsetse flies. In culture, they are grown at low densities to avoid 
selecting for monomorphism. Bloodstream cultures can also be grown in soft agar or methyl 
cellulose containing media to promote retention of pleomorphism 46. An example is the 
EATRO 1125 strain. 
Procyclic forms multiply and migrate to the foregut to form epimastigotes. Epimastigotes 
express yet another GPI-anchored surface coat protein called BARP (brucei alanine-rich 
proteins) 47. It was initially thought that all insect-stage forms except metacyclics express 
procyclins and that BARP was expressed in bloodstream forms hence its previous name 
‘bloodstream alanine-rich proteins’ 48; until transcriptomics showed 20-fold higher expression 
of BARP in epimastigotes, which led to its re-characterization and renaming 47. Epimastigotes 
divide into two geometrically unequal diploid daughter cells, and some undergo meiosis 49. 
The epimastigotes attach to the epithelium of the salivary glands and differentiate into 
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mammalian infective metacyclics, which are non-proliferative and express metacyclic VSGs 
as their surface coat. During the next blood meal, metacyclics are injected into the skin and 
differentiate to proliferative long slender forms in the bloodstream, and the cycle begins again.  
Differentiation of procyclic cells to epimastigotes and to metacyclics has recently been 
demonstrated in vitro by induced expression of RNA binding protein 6 (RBP6) 50 or directly to 
metacyclics by induced expression of RBP10 45. However, the metacyclics obtained by over-
expression of RBP6 could not progress to bloodstream forms in vitro, but only when a Q109K 
mutant of RBP6 was over-expressed 28. In T. cruzi, this differentiation is achieved by 
nutritional stress 51 or by over-expression of TcUBP1 52.  
Interestingly, the transmission stages (stumpy and metacyclics) are both non-proliferative, 
have VSG coats, are pre-adapted to their next host and are basically dead-ends if not 
transmitted: much more remains to be discovered in these vulnerable stages. Recently, some 
parasites with a different metabolic profiles from those dividing in the body fluids have been 
reported to inhabit adipose tissues of the mammal and have raised speculations concerning a 
new form of the parasite 53. 
In sum, trypanosome pleomorphism requires a robust regulation of gene expression that 
responds to nutritional requirements, host immunity, parasite density and other environmental 
cues. This control ensures both a balance between parasite and host, and parasite 
transmission. 
 
1.4 Gene regulation in Trypanosoma brucei 
Trypanosomes and related kinetoplastids have a peculiar genome arrangement; genes are 
arranged in unidirectional transcription units and virtually all genes, with the exception of those 
encoding an RNA helicase and a poly (A) polymerase, lack introns 54. This is reminiscent of 
bacteria operons and a deviation from the usual eukaryotic model. Nevertheless, polycistronic 
genome arrangement and trans-splicing have been reported in other unrelated eukaryotes like 
in nematodes 55, trematodes 56, euglenoids 57, chordates 58 and dinoflagellates 59. Because 
these are remotely unrelated eukaryotes, it is not clear whether trans-splicing was in the last 
common eukaryote or it emerged separately several times. Therefore during transcription, 
individual mRNAs are excised from the primary transcript by trans-splicing of the 5’-end with a 
spliced leader sequence and polyadenylation of the 3’-end. Apart from the spliced leader, 
which has a discrete RNA polymerase II promoter sequence 60, transcription in trypanosomes 
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was thought to initiate from loci corresponding to specific histone modifications instead of 
promotors 61. However, a recent study identified GT-rich promotors that lack specific motifs, 
and which initiate transcription and promote occupancy of less stable nucleosomes containing 
the histone variant H2A.Z 62. Genes in a transcription unit are almost always unrelated and 
each mRNA will be found in different amounts 63 indicating control. Polycistronic gene 
arrangement makes control of individual mRNA at transcription level impossible and therefore 
control of expression of individual genes can only be achieved after transcription 64; this can 
be done by regulating mRNA processing, nuclear export, stability and translation. 
Trans-splicing and polyadenylation are coupled processes. Regulation at these steps includes 
alternative trans-splicing. Genome-wide mapping of RNAseq data indicates that about 90% of 
protein coding genes undergo alternative trans-splicing 65–68 and that half of these alternative 
events are developmentally regulated 66. Alternative trans-splicing results in start codon 
skipping that prevents translation initiation, in/exclusion of targeting sequence that causes 
mislocalization, in/exclusion of regulatory elements that affect mRNA stability, and use of 
alternative open reading frames 66,68. A mathematical model proposed that variation in 
transcription-processing rates could result in a competition with the co-transcription pre-
mRNA-destruction rates, and thus affect mRNA steady states 69. 
Another gene control mechanism is by modulating the half-life of mRNA, which in 
bloodstream-form trypanosomes is a median of 13 min 63. This is mainly achieved by mRNA 
degradation, translation and storage, all these orchestrated by RNA binding proteins (RBPs). 
RBPs bind particular mRNA elements to either recruit mRNAs to degradation or translation 
machineries. During degradation, mRNAs are deadenylated by the CAF1/NOT1 complex 70,71 
followed by decapping by an ApaH-like phosphatase (ALPH1) 72, and are then degraded in 
the 5’-3’ direction by the XRNA exoribonuclease, and in the 3’-5’ direction by the exosome 73.  
 
1.4.1 Gene regulation by RNA binding proteins 
In many scenarios, RBPs bind cis-elements in the non-coding regions of mRNA particularly 
the 3’UTR, and modulate mRNA stability 35,45,74–76. Other proteins, including translation 
initiation factors, usually bind the 5’UTR or the mRNA cap. Regulation by elements in the 
coding sequence is also possible 77. Trypanosoma brucei has over 155 RBPs, which is a 
figure higher than bioinformatics predictions, because it includes proteins that have no 
obvious RNA binding motif yet co-purify with poly(A) RNA 78. RBPs have extensively been 
reviewed and the functions of many are as yet unknown 79–81 (Table 1).  
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The effect of a protein on gene expression can be analysed using a tethering assay. This 
method exploits the affinity between the RNA-binding domain of the lambda bacteriophage 
anti-terminator protein N (λN-peptide) and its target boxB nucleotide sequence 82. The protein 
of interest is expressed as a fusion with the 22-amino acid λN peptide, and multiple 19-
nucleotide boxB sequences are added to the 3’UTR of a reporter gene e.g. chloramphenicol 
acetyltransferase or luciferase. The protein of interest would therefore be recruited to the 
reporter mRNA and its effect determined by assaying the fate of the reporter. Alternatives to 
the λN-boxB setup involves MS2/R17 coat proteins and their binding sequences 83, or other 
known peptide-nucleotide interactions. 
 
Table 1: Examples of RNA binding proteins in Trypanosoma brucei 
Protein Proposed function Targets Effect on 
reporter84 
PABP1, 
PABP2 
Translation85 All mRNA Activator 
UBP1, UBP2 Likely in cell division 86 Not specific ND 
RBP42 Regulating energy metabolism87 Energy metabolism 87 Activator 
PTB1, PTB2 Splicing, mRNA stability 76,88 Not specific Activator 
RBP6 Differentiation 50 Unknown ND 
RBP10 Maintaining bloodstream profile 45 Procyclin mRNA, 
RBPs, energy 
metabolism 
Repressor 
ALBA 1-4 Translation 89 Unknown ND 
HnRNPF/H Developmental regulation, 
splicing, mRNA stability 90 
 ND 
ZC3H11 Heat shock response 91–93 Chaperone mRNA Activator 
ZC3H12 Unknown XRNA (not verified) 94 ND 
ZC3H13 Unknown Not specific 94 Repressor 
ZC3H20 Developmental regulation 95 MCP12, trans-sialidase Activator 
ZC3H18 Differentiation 96 Unknown ND 
ZFP1,ZFP2 Differentiation to procyclic  Likely 
activators 97 
ZFP3 Differentiation to stumpy Stumpy enriched 
transcripts 98 
Activator 98 
PUF9 Cell cycle 75 LIGKA, PNT1 and Activator 75 
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PNT2 
PUF1 Unknown Retrotransposon RNA 
99 
ND 
PUF2 Unknown Unknown Repressor100 
PUF5 Unknown RNAs in procyclic 101 ND 
PUF7, PUF10 rRNA maturation 102 unknown ND 
ND: not effect detected 
RNA recognition motif (RRM) domain proteins are those that have at least one RRM and 
include poly(A) binding proteins (PABP), U-rich-sequence binding proteins (UBP), 
polypyrimidine tract binding protein (PTB), heterogeneous nuclear ribonucleoproteins 
(HnRNP) and other RBPs. Zinc finger domain proteins of the CCCH family bind RNA and 
sometimes function in developmentally regulated processes. ALBA (acetylation lowers binding 
affinity) domain proteins are versatile proteins that regulate gene expression. Their binding to 
RNA is regulated by acetylation/deacetylation, hence their name. They are involved in 
chromatin modification, transcription/translation regulation, development and differentiation 
processes. In trypanosomes they have been suggested to regulate the initiation steps of 
translation as they interact with PABPs, ribosomal protein P0 and cap binding protein 
TbEIF4E4 (Alba3) 89,103. T. brucei has 11 pumilio domain proteins (PUF) which are mostly 
repressors of gene expression except for PUF9, and seem to have versatile functions, which 
may in some cases be redundant. The pumilio domain protein PUF3 will be a focus of my 
thesis. 
 
1.4.2 Pumilio domain proteins 
The name PUF was coined from Pumilio and Fem3 mRNA binding factor (FBF) which were 
the first pumilio domain containing proteins to be described respectively in Drosophila 
melanogaster and Caenorhabditis elegans. PUF proteins have a unique structure (Figure 2); it 
consists of eight PUF repeats, collectively called the PUF domain, arranged in a concave arc 
that binds RNA. A PUF repeat is made up of 3 short helices and the second helix in each 
repeat recognizes a single base. Five residues in the second helix coordinate binding: the 
residues at position 1 and 5 interact with an RNA base 104,105. Each PUF domain generally 
recognizes eight bases in a target RNA. There may be exceptions as some PUF proteins 
have less than the usual eight repeats while others have more 75,105. Artificially higher numbers 
of repeats can give more binding specificity for various applications in biotechnology 105. 
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Figure 2: PUF domain structure and some consensus recognition motifs. Left panel is a stick 
model structure of Arabidopsis thaliana Pumilio 2. The eight PUF repeats (R1-R8) recognize 
eight bases in an RNA (UGUANAUA). The image was taken from 106. Right panel shows 
consensus sequences obtained from 3’UTRs of PUF targets from human, yeast and 
Drosophila. The height of the nucleotide represents the probability that it occurs at that 
position, while conserved positions are shaded in yellow. The image was taken from 107 
In multicellular eukaryotes and yeast, PUF proteins are involved in cell differentiation and 
development functions; they bind their targets causing mRNA degradation or translation 
repression, though target stabilization has been reported 75,108. Their numbers range from one 
in Drosophila, three in humans, five in yeast to 25 in Arabidopsis 106 and 11 in trypanosomes, 
attesting to their evolutionary conservation among eukaryotes. PUM and Nanos together 
repress the hunchback mRNA in Drosophila embryos to allow normal development of the 
posterior 109. In the hermaphrodite C. elegans, FBF mediates the sperm-oocyte switch 110. 
Human PUM2 in complex with DAZ, is implicated in maintenance of germline stem cells 111. 
In trypanosomes, depletion of PUF1 has no effect on the transcriptome or growth of cells in 
culture 99 and neither does it associate with polysomes. It was shown to preferentially bind 
retroposon RNA but its function remains unknown. PUF2 also does not associate with 
polysomes and it represses mRNA in a tethering assay. It is essential for growth of 
bloodstream forms and its depletion favours a non-specific accumulation of mRNAs with short 
coding sequences 100. Nonetheless, its biological function is not really understood. PUF5 is not 
essential for growth of either bloodstream or procyclic forms and neither is it required for 
differentiation of bloodstream to procyclic forms. Its over-expression seems to inhibit cell 
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growth in procyclic forms 101 and its function is unknown. However, its upregulation in 
epimastigotes suggests that it may function primarily in epimastigotes 28. Unlike other PUF 
proteins, PUF7 and 10 are localized in the nucleolus and are involved in rRNA maturation 102, 
and together with the ribosome biogenesis protein BOP1 and NRG1 (nucleolar regulator of 
GPEET1), are negative regulators of GPEET mRNA 44. PUF9 is extraordinary in that it 
stabilizes its target mRNAs. It stabilizes the mRNA encoding a kDNA ligase α (LIGKA) and 
two other targets named PUF Nine Target (PNT1 and PNT2) during S-phase via a motif 
UUGUACC 75. 
In summary, apart from PUF7, 9 and 10, the functions of the pumilio proteins remain unclear. 
Despite concerns over functional redundancy 99, different phenotypes in PUF mutants, the 
number of PUF repeats, localization and independence of PUF7/10 (which share functions 44) 
are suggestive of non-redundancy. This work will focus on PUF3 which has previously been 
detected among other strong repressors in a genome-wide tethering screen 84. 
 
1.5 Control of translation 
Messenger RNAs (mRNAs) in eukaryotes have a modified guanosine residue attached to the 
first transcribed nucleotide by a 5’-5’ triphosphate linkage, followed by methylated nucleotides 
that make up the cap. Lower eukaryotes like yeast have cap 0 (m7GpppN), where m is 
methylation, p is phosphorylation and N is any nucleotide, while higher organisms have 
extensively methylated caps i.e. cap 1 (m7GpppNm) or cap2 (m7GpppNm pNm) 112. During 
cap-dependent translation initiation, eukaryotic initiation factor eIF4E binds to the cap and 
recruits the scaffold protein eIF4G, which binds the DEAD-box RNA helicase eIF4A. The three 
initiation factors are together called eIF4F, which via eIF3 recruits the small ribosome subunit 
that is bound to the charged methionyl-tRNA and other factors to the cap, to form the 43S pre-
initiation complex (PIC). This unwinds the 5’ secondary structures and begins to scan the 
mRNA in the 5’-3’ direction for the start codon AUG. On finding it, eIF5 and eIF5B promote 
hydrolysis of the GTP attached to eIF2, eIFs fall off and the large ribosomal 60S subunit is 
recruited to form the 80S ribosome with the methionyl-tRNA in the P-site 113. Poly(A) binding 
proteins (PABP) can bind eIF4G to circularize the mRNA and create the closed-loop 
configuration, which enhances translation and recycling 114.  
With the aid of elongation factors (eEF), the first elongation tRNA bearing an amino acid is 
delivered to the A-site in an eEF1A·GTP·aminoacyl-tRNA complex. The peptidyl transferase 
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action of the 60S subunit catalyses peptide bond formation between the amino acids on the 
tRNAs in the A- and P-sites, leaving behind a deacylated tRNA. Hydrolysis of the GTP 
promotes the mRNA to move by 3 nucleotides to position the next codon on the A-site, the 
peptidyl-tRNA on the P-site and the deacylated tRNA on the E-site. The next tRNA is brought 
into the A-site and the process repeats until a stop codon is reached. The release factor eRF1 
then occupies the A-site and catalyses the hydrolysis of the ester bond linking the peptide 
chain to the tRNA in the P-site and terminates translation elongation 115. 
Control of translation is found in all organisms particularly at the initiation step. Yeast has only 
one canonical (class 1) eIF4E, mammals two, C. elegans four, A. thaliana five, and Drosophila 
six. Besides these canonical ones are class 2 eIF4Es, which do not interact with eIF4G and 
are repressors of translation. These are exemplified by eIF4E2/4EHP in mammals, d4EHP in 
Drosophila, nCBP in A. thaliana and IFE-4 in C. elegans 115. For example, mammalian 4EHP 
is recruited to a subset of mRNA by GIGYF2 and various RBPs including ZNF598, to form a 
repressive complex that is essential during embryonic development 116. Another relevant RBP 
is tristetraprolin, which recruits 4EHP-GIGYF2 to mRNAs with AU-rich elements 117,118. A 
further example is Drosophila 4EHP (d4EHP), which is implicated in early development: 
together with the RBP bicoid d4EHP represses translation of caudal mRNA 119, and with the 
RBPs Brat (brain tumor), Pum (pumilio) and Nos (nanos), it represses the hunchback mRNA 
120. Arabidopsis nCBP (novel cap-binding protein) is preferentially expressed in early stages of 
cell growth 121 and though classified as class 2 eIF4E 115, it interacts with the eIF4G isoform 
eIF(iso)4G but not with eIF4A 122. RNAi of IFE-4 in C. elegans causes defects in laying of eggs 
but its mechanism of action in not known 123. The presence of multiple differentially expressed 
eIF4Es with only a few dedicated to general translation and some with a repressive role, is 
reminiscent of a control mechanism. This has potential in modulating mRNA selection for 
translation 124. 
Regulation of translation initiation steps can also be achieved by eIF4E-binding proteins (4E-
BP), which compete with eIF4G for binding eIF4E to prevent initiation 125. Binding of eIF4G to 
the dorsal side of the cap binding protein eIF4E is via a canonical YXXXXLΦ motif where X is 
any amino acid and Φ is a hydrophobic amino acid 125. This motif is also used by 4E-BP to 
bind eIF4E 126 hence binding of eIF4G and 4E-BP is mutually exclusive 127. A second, non-
canonical motif binds eIF4E on the lateral side and enhances binding by the first motif 128. 
These motifs are flanked by phosphorylation sites that modulate binding to eIF4E 129,130. 
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4E-BPs include 4E-T, 4E-BP1-3 and Angel1 in human, Cup1, Mextli and 4E-T in Drosophila, 
Caf20 and Eap1 in yeast, and IFET-1 in C. elegans 125. Mammalian 4E-BPs are 
phosphorylated by mTOR (mammalian target of rapamycin) kinase that prevents them from 
binding eIF4E, and this promotes translation of mRNAs with terminal oligopyrimidine tracts 131. 
Stress conditions and inhibitors of mTOR including rapamycin and Torin 1, inhibit translation 
via the mTOR pathway 131,132. Drosophila Cup is homologous to vertebrate 4E-T and it 
represses Oskar and Nanos mRNA via Bruno and Smaug RBPs respectively in early life 
development 133,134 in a cap-dependent mechanism. It inhibits the recruitment of the small 
ribosomal sub-unit to Oscar mRNA via a cap-dependent mechanism 135. Angel is a member of 
the CCR4 deadenylase family and can outcompete eIF4G for eIF4E binding in vitro but not in 
vivo 136. Mextli resembles eIF4G but without the eIF3A binding site, can drive translation in 
vitro and is required in embryogenesis 137. Cap20 and Eap1 are dephosphorylated during 
stress response and inhibit translation 138. 
In addition to blocking binding of eIF4G, 4E-BP can repress target mRNA independent of 
eIF4E as in the case of 4E-T and Cup1, or recruit decapping (Eap1) or deadenylation (Cup1) 
enzymes that destine the mRNA for degradation (reviewed in 125). For example, human 4E-T 
is enriched in P-bodies where it is believed to represses translation of bound mRNA 139. When 
tethered to a reporter mRNA, it can also represses translation in an eIF4E/P-body 
independent mechanism probably by its increased association with the decapping and 
deadenlyation machineries 140. Tethering GIGYF2 also represses a reporter mRNA 
independent of 4EHP by recruiting the CCR4/NOT deadenylation complex. Repression by 
4EHP requires GIGYF2 141,142. GIGYF2 also associates with Ago2 to repress translation via 
miRNA-mediated silencing 143. Drosophila Cup represses Oskar mRNA independent of eIF4E 
by Bruno-dependent oligomerization of Oskar mRNA that form assemblies of 50S-80S 
“silencing particles”, which are inaccessible for translation 135. 
Trypanosoma and their close relative Leishmania have six EIF4Es 144, five EIF4G145, two 
EIF4A146 and two poly(A) binding proteins 85 (Leishmania has three147) homologs (reviewed in 
148). In various combinations, they form different eIF4F complexes with EIF4E4-EIF4G3-
EIF4A1 complex as the main eIF4F. EIF4E3 binds EIF4G4, EIF4E5 binds EIF4G1/2 and 
EIF4E6 binds EIF4G5, but EIF4E1 and 2 do not bind any of the eIF4Gs. Instead, EIF4E2 
binds a stem loop binding protein (SLBP) – a homolog of mammalian histone mRNA-binding 
protein SLBP149. EIF4E1 binds a 4E-BP called 4E-interacting protein (4EIP) conserved only in 
kinetoplastids 150,151. Works on 4EIP-EIF4E1 have been done in Leishmania major; Lm4EIP 
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binds LmEIF4E1 in promastigotes (the insect form of the parasite) whereas in amastigotes 
(the form in the mammal), their interaction is abrogated and the expression of Lm4EIP but not 
LmEIF4E1 is reduced 150. Structural analysis of this interaction suggests that binding of 
Lm4EIP destabilizes the cap-binding of LmEIF4E1 possibly through change in molecular 
conformation, thus inhibiting translation initiation 151. However, it is not yet clear whether in the 
first place LmEIF4E1 can initiate cap-dependent translation. An alternate hypothesis therefore 
is that Lm4EIP releases LmEIF4E1 from the cap thus allowing binding of the cap by 
translation potent eIF4Es 151. The exact mechanism of action is unknown. 
 
1.5.1 Trypanosoma brucei 4E-interacting protein (Tb4EIP) 
Tb4EIP has been studied by a number of people in our lab and their preliminary data are 
outlined in the following paragraphs. (Complete data was recently published in ref 152.) 
Tb4EIP, like in Leishmania, interacts only with TbEIF4E1 and not with the other eIF4Es, at 
least in bloodstream forms. This interaction was abolished when the N-terminal canonical 
motif YXXXXLΦ was deleted. The interaction in Leishmania was developmentally regulated, 
but it is still unknown whether the interaction is sustained in the procyclic forms. 
Both TbEIF4E1 and Tb4EIP were previously identified as strong repressors in a tethering 
screen 78,84. Tb4EIP represses mRNA stability and translation when tethered to the 3’UTR of a 
reporter gene. Repression was independent of TbEIF4E1 interaction and the C-terminal 
fragment was sufficient for repression. It would be interesting to find out the reverse; whether 
TbEIF4E1 represses gene expression in the absence of Tb4EIP.  
Pull-down experiments illustrated that Tb4EIP targets mRNAs with low ribosome density and 
short half-lives. In addition, mass-spectrometry results showed that Tb4EIP consistently 
bound TbEIF4E1 but no other obvious protein partners were found. Further, none of the yeast 
2-hybrid interaction candidates, except TbEIF4E1, could be confirmed in trypanosomes. 
 
1.6 Aims of the study 
The general aim was to determine the function of Tb4EIP and PUF3 particularly during 
differentiation. Specific aims were as follows: 
1. To determine whether Tb4EIP and PUF3 are essential in Trypanosoma brucei 
2. To determine whether Tb4EIP and TbEIF4E1 interact in procyclic forms 
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3. To determine the effect of tethering TbEIF4E1 in the absence of Tb4EIP 
4. To identify protein binding partners of PUF3 and its target mRNAs 
5. To determine whether Tb4EIP and PUF3 are required for differentiation of 
Trypanosoma brucei 
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2.0 Materials and methods 
2.1 Culture of Trypanosoma brucei 
All the cells used in this thesis were based on stable cell lines constitutively expressing a 
tetracycline repressor, which for simplicity are referred to as wild-type. Lister 427 bloodstream 
forms (monomorphic) were cultured in HMI-9 media supplemented with 5% PenStrep (Gibco), 
1.5 mM L-cysteine, 0.2 mM β-mercaptoethanol and 10% fetal bovine serum (Heat inactivated 
at 55°C for 1 hr) at 37°C and 5% CO2, and were diluted periodically as required. EATRO 1125 
bloodstream forms (pleomorphic) were cultured in HMI-9 media containing 1.1 % methyl 
cellulose (Sigma, M0512) to maintain their pleomorphism. Procyclic forms were cultured at 
27°C in MEM media supplemented with 5% PenStrep (Gibco), 7.5 mg/l hemin and 10% of 
heat inactivated fetal bovine serum at a density between 105 - 4×106 cells/ml. 
Differentiation of bloodstream slender forms to stumpy forms was done by allowing a starting 
density of 5-7×105 cells/ml to peak at 3-4×106 cells/ml, and later descend to 106 cells/ml. This 
takes approximately 48 hrs. Differentiation to procyclic forms was done by adding 6mM cis-
aconitate to 106 cells/ml slender or stumpy forms and incubating at 27°C for 24 hrs and 
thereafter transferring the cells to MEM.  
Growth curves were performed using media without drugs whereas 100ng/µl of tetracycline 
was used when needed. Cell densities were determined using a Neubauer chamber. 
 
2.2 Cell transfections 
All the transfections were aimed at genomic integration by homologous recombination to 
obtain stable cell lines. To transfect bloodstream forms, 1.5×107 cells (density of 0.5-1×106 
cells/ml) were collected at 900×g for 10 min at 4°C and the pellet re-suspended in 130 µl of 
ice-cold Amaxa buffer (90 mM NaH2PO4, 0.15 mM CaCl2, 5 mM KCl, 50 mM HEPES, pH 7.3). 
10 µg of linearized DNA was added to the cells in a cuvette and the cells electroporated using 
the free proprietary program X-001 of an Amaxa system as previously described 153. The cells 
were transferred to 25ml of HMI-9 media and placed in growth conditions for 6 hours before 
adding the selection drug and seeding at a density not exceeding 5×105 cells/ml on a 24 well 
plate. To transfect procyclic forms, 2×107 cells (growing density of 1.5-3×106 cells/ml) were 
pelleted and re-suspended in ice-cold ZPFM buffer (132 mM NaCl, 8 mM KCl, 8 mM 
Na2HPO4, 1.5 mM KH2PO4, 1.5 mM MgOAc.4H2O, 90 μM CaOAc2, pH 7.0) containing 10µg of 
linearized DNA in a cuvette. The cells were electroporated using the BTX system set at 1.5 
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volts and resistance at R2. Cells were placed in growing conditions for 6 hrs before addition of 
a selection drug. Cells were counted and diluted if necessary to a density of 3-5×106 cells/ml 
in MEM media, and seeded on a 24 well plate. The plate was sealed along the lid with tape to 
prevent evaporation of medium. 
 
2.3 Indirect immunofluorescence microscopy 
For immunofluorescence microscopy using non-chambered microscope slides, cells were 
smeared on a slide, air-dried and fixed using methanol for 10 min at -20°C. Alternatively, the 
cells were fixed in 4% paraformaldehyde at room temperature for 20 min, washed and 
smeared on slides. The slides were either stored at 4°C or analysed immediately. All the 
following steps were done at room temperature. The slides were placed in PBS for 5 min to 
rehydrate the cells then permeabilised using 0.2% Triton-X for 20 min. Cells were blocked with 
0.5% gelatin for one hour and incubated with a primary antibody (dissolved in 0.5% gelatin) for 
one hour. The slides were washed three times with PBS and incubated in the dark with a 
secondary antibody containing a fluorescence dye for one hour. The slides were washed three 
times and incubated for 15 min with 1μg/ml DAPI solution. Three more washes were made 
and the slides air-dried before mounting with 90% glycerol-PBS. The cover slips were sealed 
to the slides using nail polish. Images were acquired using an Olympus IX81microscope and 
analysed with Olympus xcellence software or image J. 
 
2.4 Protein detection by Western blotting 
For Western blotting, 5×106 cells were collected at 900×g for 10 min, washed with PBS, re-
suspended in Laemmli buffer (4% SDS, 20% glycerol (v/v), 120mM Tris-HCl, 0.02% (w/v) 
bromophenol blue) and heated at 95°C for 5 min. The cell lysates were analysed on either 8, 
10 or 12% SDS-polyacrylamide gel as required. For experiments analysing PAD1, the cell 
lysates were not heated prior to electrophoresis and were run at 4°C as described by Dean 27. 
Blotting was done by wet transfer (BIO RAD). Blots were blocked for at least one hour with 5% 
skimmed milk, incubated with a primary antibody for one hour, washed thrice with TBS-T 
(TBS, Tween-20) for five minutes per wash and incubated with a secondary antibody for one 
hour. Blots were washed thrice for 10 min per wash, reacted with ECL (perkinelmer) and the 
signal detected using x-ray films. 
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2.5 RNA preparation and Northern blotting 
To obtain at least 10µg of RNA, 3×107 of log phase (1.0-1.3×106 cells/ml) growing 
bloodstream-form cells were collected at 900×g for 10 min and RNA extracted using TriFast 
reagent according to the manufacturer’s protocol. RNA concentrations were determined using 
a Nanodrop spectrophotometer and the RNA stored at -80°C or used immediately. rRNAs 
were depleted from whole RNA extracts before RNAseq using a cocktail of DNA 
oligonucleotides targeting rRNAs with an RNaseH based method as previously described 93. 
The RNA was electrophoresed on a formaldehyde agarose gel, blotted on a nylon membrane 
by downward capillary for at least 4 hrs followed by UV cross-linking of RNA to the membrane 
using a Stratagene® UV cross-linker. Prior to probing, the blot was blocked using pre-
hybridization buffer (5×SSC, 0.5% SDS, 5× Denhardt’s solution, 100µg/ml Salmon sperm 
DNA) at 65°C. For probing the spliced leader, the pre-hybridization buffer was similar to the 
previous one except for 6×SSC and 0.05% sodium pyrophosphate. Probes made from PCR 
products were prepared using PrimeIt kit (Stratagene), and those from oligonucleotides using 
phosphonucleotide kinase (NEB) to incorporate radioactive nucleotides into the probe. The 
northern blot was incubated overnight with at least 2×106 cpm/ml of the probe at 42°C or 65°C 
for an oligonucleotide or a PCR-product probe respectively. The blot was washed with buffer 
(2 x SSC, 0.1 % SDS) twice for 10 min per wash at room temperature and once for 15 min at 
65°C then exposed to a phosphorimaging film before developing the autoradiographs with a 
phosphorimager (Fugifilm FLA-3000). 
 
2.6 Southern blotting 
At least 5µg pf genomic DNA was digested using appropriate restriction enzymes and 
electrophoresed on an ethidium bromide containing agarose gel. The gel was washed in 
hydrolysis buffer (0.25 M HCl) for 15 min, in denaturing buffer (1.5 M NaCl, 0.4M NaOH) for 
15 min and in neutralizing buffer (1.5 M NaCl, 0.5 M Tris-Cl pH7.5) for 15 min before blotting 
onto a nylon membrane and processing as described for the northern blotting. 
 
2.7 Cell fractionation by digitonin 
108 cells were collected at 900×g and washed three times in trypanosome homogenization 
buffer, THB (25mM Tris-Cl pH 7.8, 1mM EDTA, 150mM NaCl, 0.3M sucrose). The washes 
consisted of centrifugation (900×g, 5 min, 4°C) and re-suspension by gentle agitation of the 
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tube instead of pipetting. The cells were eventually re-suspended in 100µl of THB containing 
2µg/ml leupeptin, 1mM DTT and always placed on ice. Using a stock of 0.9mg/ml of digitonin 
(dissolved in THB by heating at 95°C for 5min), aliquots of different digitonin concentrations 
were prepared and their volumes adjusted to be similar to each other and set at room 
temperature. 107 cells (10µl) were pipetted directly into the digitonin aliquots (at most, three 
tubes at a time) and incubated for 4 min at 25°C. Subsequently, the tubes were centrifuged 
(15,871×g, 1.5 min, 4°C) and both the supernatants and pellets collected separately, and 
dissolved in Laemmli buffer. The samples were analysed by Western blotting. 
 
2.8 Chloramphenicol acetyltransferase (CAT) assay 
2×107 cells were collected at 900×g for 10 min and washed three times with PBS. The pellet 
was re-suspended in 100μl of CAT buffer (100mM Tris-HCl pH 7.8) and freeze-thawed three 
times using liquid nitrogen and a 37°C heating block. The supernatants were collected by 
centrifugation at 10,000×g for 5 min and kept in ice. The protein concentrations were 
determined by Bradford assay (BioRad) according to the manufacturer’s protocol. For each 
setup, 0.5μg of protein in 50μl of CAT buffer, 10μl of radioactive butyryl CoA (14C), 2μl of 
chloramphenicol (stock: 40mg/ml), 200μl of CAT buffer and 4ml of scintillation cocktail were 
mixed in a Wheaton scintillation tube HDPE (neoLab #9-0149) and the incorporation of 
radioactive acetyl group on chloramphenicol was measured using program 7 of Beckman LS 
6000IC scintillation counter. 
 
2.9 Co-immunoprecipitation 
108 cells were collected at 4°C and washed twice in ice-cold PBS. The cells were lysed in lysis 
buffer (50mM Tris-Cl pH 8.0, 120mM NaCl, 0.5% IGEPAL, 50ug/ml leupeptin) by passing 
them 15 – 20 times through a 21-gauge needle on ice. The lysate was precleared by 
centrifugation at 10,000×g, NaCl increased to 900mM, and then incubated with pre-washed 
myc/V5-antibody conjugated agarose beads for 2 hrs at 4°C. The unbound lysate was 
discarded and the beads washed three times with wash buffer (50mM Tris-Cl pH 8.0, 900mM 
NaCl, 0.5% IGEPAL) before adding Laemmli buffer and analysing by SDS-PAGE and 
Western blotting.  
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2.10 Tandem affinity purification (TAP) 
6-7×109 cells were collected at 900×g at 4°C for 15 min in 500 ml centrifuge containers. The 
cell pellet was washed twice in ice cold PBS, snap frozen in liquid nitrogen and stored at -
80°C or used immediately. The cells were lysed in IPP10 buffer (10mM Tris-HCL (pH 7.8), 
10mM NaCl, 0.1% IGEPAL, 50μg/ml leupeptin) by passing them through a 21-gauge needle 
15 – 20 times. The lysate was cleared by centrifugation at 10,000×g for 10 min and the 
concentration of NaCl adjusted to 150mM before loading onto a 0.8×4 cm Poly-Prep column 
(BioRad) containing IgG sepharose beads that had been prewashed in IPP150 buffer (10mM 
Tris-HCL (pH 7.8), 150mM NaCl, 0.1% IGEPAL). This was incubated at 4°C for 2 hours with 
gentle rocking. The beads were washed twice with 10ml IPP150 buffer and once with 10ml 
TEV cleavage buffer (IPP150 buffer, 1mM DTT, 0.5mM EDTA). The beads were re-
suspended in 800μl TEV cleavage buffer and incubated with TEV protease at 15-20°C for 2 
hours with gentle rocking. The eluate was collected and transferred to a second column 
containing calmodulin beads in calmodulin binding buffer (IPP150 buffer, 10 mM β- 
mercaptoethanol, 1 mM MgAc2, 1 mM imidazole, 2 mM CaCl2), and incubated for 2 hours at 
4°C. The beads were washed three times with calmodulin binding buffer and the proteins were 
eluted using 2mM EGTA. The proteins in the eluate were concentrated using trichloroacetic 
acid and dissolved in Laemmli buffer. This was electrophoresed for a short time so that the 
sample dye ran approximately 1.5cm. The gel was then submitted to the sequencing facility at 
ZMBH (Heidelberg) for mass spectrometry. 
 
2.11 RNA immunoprecipitation (RIP) 
This procedure was done in a similar manner as the TAP purification with the exception that 
the cells were UV-irradiated before lysis and only one purification step was done. 
Approximately 3×109 cells were collected at 900 ×g at 4°C for 15 min, re-suspended on a petri 
dish in 30 ml of the supernatant on ice and UV- irradiated twice using a Stratagene UV 
crosslinker with an energy of 3 kilo joules. The cells were pelleted again in 4°C at 2000×g for 
5 min and washed twice with ice cold PBS. Cells were lysed in IPP10 buffer consisting of KCl 
in place of NaCl and containing RNase inhibitor (RNasin, Invitrogen), by passing them through 
a 21-gauge needle 15-20 times. The lysate was cleared by centrifugation at 10,000×g for 10 
min, KCl concentration adjusted to 150 mM and loaded onto a column containing prewashed 
sepharose beads similar as in the TAP purification. A small volume of the lysate equivalent to 
1.5×107 cells was collected as the input fraction and treated with 0.2mg/ml proteinase K, 8mM 
31 
 
EDTA, 0.2% SDS at 45°C for 15 min before adding TriFast-FL reagent (Peqlab). The columns 
were incubated at 4°C for 2 hours with gentle rocking and the unbound lysate collected. This 
was also subjected to proteinase K treatment as described for the input fraction. 
Subsequently, the beads on the column were washed twice with IPP150 buffer and once with 
TEV cleavage buffer, re-suspended in 500µl of TEV cleavage buffer containing TEV protease 
and incubated at 15-20°C for 2 hours with gentle rocking. The cleaved product (bound) was 
treated with proteinase K and mixed with TriFast-FL reagent. The three fractions in TriFast-FL 
were stored at -80°C and later used for RNA extraction according to the manufacturer’s 
protocol. RNA concentrations were determined using a NanoDrop® or a Qubit® 
spectrophotometer and submitted to the Next-generation sequencing facility in Bioquant 
(Heidelberg) for RNAseq. 
 
2.12 RNA-sequencing data analysis 
Fastq files were used as input in TrypRNAseq – an in-house pipeline for RNAseq 
(https://github.com/klprint/TrypRNAseq). Briefly, reads were taken through quality control, 
mapped on the T. brucei genome (TREU927), and the number of reads aligning to coding 
sequences (CDS) determined. The fold changes were compared between RNAi induced and 
un-induced samples using DESeq2 154. 
For RNA immunoprecipitation data, only genes with read counts ≥3 in all of the samples were 
considered in the analysis. The read counts were normalized to reads per million (RPM) and 
the average RPMs of the bound fraction were compared against the average RPMs of the 
unbound. Genes with fold change ≥2 were taken as putative targets. Motifs were predicted by 
DREME (Discriminative Regular Expression Motif Elicitation) 155 using 3’UTRs of the putative 
targets as input, while those of unbound genes served as controls. Genes lacking 3’UTR 
annotations were excluded from motif searches requiring 3’UTR sequence inputs. 
 
2.13 Sequence retrieval and domain analyses 
Trypanosomatid sequences were obtained from TriTrypDB (http://tritrypdb.org/tritrypdb/). 
Domains were detected using SMART (Simple Modular Architecture Research Tool: 
http://smart.embl-heidelberg.de/, 156. Cladogram and sequence alignments were done using 
Simple phylogeny tool and Clustal Omega respectively, provided by EMBL-EBI services 157, 
and alignments were processed using Jalview 158.  
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Drosophila datasets previously used for analysis of Hrp48-TRIBE 159 were also used in this 
thesis for comparison and were downloaded from the Sequence Read Archive (SRA) 
database with the following ID: wild-type: SRR3177675, uninduced: SRR3177677, induced: 
SRR3177678. Hrp48 is a homolog of the mammalian heterogeneous nuclear 
ribonucleoproteins A/B family that participates in gene regulation in the circadian pathway 159. 
 
2.14 TRIBE data analysis 
2.14.1 Quality control and alignment 
The analysis was similar in most aspects as originally described 159. It involved RNA reads for 
three samples and DNA reads of EATRO1125 T. brucei strain in fastq format. All reads were 
first put through a stringent quality control trimming procedure to ensure very high quality 
reads hence high confidence in the mutations to be detected. Trimming was done using 
Trimmomatics 160 with the following options: HEADCROP:4 LEADING:25 TAILING:25 
CROP:47 MINLEN:19 AVGQUAL:30. This allowed up to 25 bases to be removed on both 5’ 
and 3’ ends from reads with an average quality below 30 phred score. Four bases were 
removed from the 5’ end of all reads since the quality of these first bases is usually low. 
Reads were cropped to 47 bases and only those with a minimum length of 19 bases were 
retained. The RNA reads were aligned to the genome of T. brucei TREU927 using BWA 
(Burrows-Wheeler Aligner), and samtools used to sort and index the alignments. DNA reads 
were instead aligned using bowtie2 161 with the option “--sensitive”. It should be noted that the 
TREU927 genome was used only as a reference for alignments and not for detecting TRIBE 
sites. Instead, DNA reads from EATRO1125 were used to avoid inclusion of single nucleotide 
polymorphism (SNPs). A perl script 159 was used to generate an alignment that contained only 
unique reads, and to convert the alignment into a table. Columns in this table represented 
each genomic locus while rows represented nucleotide bases. The number of rows hence 
represented the depth of the alignment. Tables generated for each sample were queried using 
MySQL version 8.0 database management system (Oracle). 
 
2.14.2 Detection of edited sites 
All A>G mutations were defined as loci with A>80% and G=0% in genomic DNA table and 
G>0% in RNA table. For genes in the reverse strand, T>C mutations were considered. These 
first results were referred to as raw results. Endogenous edit sites defined as loci with <10% 
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A>G editing and alignment depth below 20, were removed from each raw result. All edited 
sites in control cell line were subtracted from the experimental cell lines to give the actual 
edited sites. Annovar 162 was used to annotate edited sites while Microsoft Excel was used for 
analysis. Sequence motifs were predicted using DREME (Discriminative Regular Expression 
Motif Elicitation) 155 with sequences upstream/downstream of the edited site as the input. 
 
2.15 List of plasmids and primers  
ID Sequence Plasmid Purpose 
cz5789 taacaagcttcatgaggaaagctggagca pHD2729 MKT1-like-myc 
cz5790 tattggatccgtgaggaatcggttcttg pHD2729 MKT1-like-myc 
cz5791 tataccgcggaatcatctttagcgtttc pHD2730 V5-MKT1-like 
cz5792 tatatctagattgtgcttcccccgtctg pHD2730 V5-MKT1-like 
cz5793 atatctcgagatgaggaaagctggagca pHD2730 V5-MKT1-like 
cz5794 atatgggccctatttgctccacctccca pHD2730 V5-MKT1-like 
cz5830 tatagttaacgtttttctgacagttgtacgcct pHD2736 TUT3-myc 
cz5831 tataccgcggcttttctcattttccagg pHD2737 V5-TUT3 
cz5832 tatatctagaatcctggtaaatgggcta pHD2737 V5-TUT3 
cz5834 tatagggcccagagagagcgcggcatggtgcac pHD2737 V5-TUT3 
cz5835 tatagggcccatgatatttttttttaaaaaacgataccacgtgttcttg pHD2736 TUT3-myc 
cz5841 tatactcgagatgatatttttttttaaaaaacgataccacgtgttcttg pHD2737 V5-TUT3 
cz5866 ggcccccggctggtattggtggtggcgg 
 
sequencing 
pHD2729 
cz5867 aatagcagcgtaaattatctagacaggg 
 
sequencing 
pHD2729 
cz5868 agctggagccccttgtgcggacccgcg 
 
sequencing 
pHD2736 
cz5869 taacctcggccgtcacctatcccctgac 
 
sequencing 
pHD2736 
cz6141 tataggtaccccacttctggcgctgctactgtttac 
pHD2828 
and 
pHD2829 TUT3 KO 
cz6142 tatactcgaggcaagctaaggtacttctcgacctttgc 
pHD2828 
and 
pHD2829 TUT3 KO 
cz6143 tatagaattcttgatgttggtacttcttcgctgaagtgg 
pHD2828 
and 
pHD2829 TUT3 KO 
cz6144 tataccgcggcgaatttgtacatggtgactaaacattaaccg 
pHD2828 
and 
pHD2829 TUT3 KO 
cz6194 catttcaacaacaacttccgttgacctttgttgtgcg 
 
screen TUT3 KO 
cz6216 tataggtaccgtggttagcggaagtagcagtagtgcaag pHD2851 PUF3 KO 
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and 
pHD2852 
cz6217 tatactcgagcctatatacccaaaatgataccttaagtg 
pHD2851 
and 
pHD2852 PUF3 KO 
cz6218 tatagaattcactcccatggccaagtgttttagtggtgg 
pHD2851 
and 
pHD2852 PUF3 KO 
cz6219 tataccgcggcgtggaaacacttgtggtaaccccgttc 
pHD2851 
and 
pHD2852 PUF3 KO 
cz6220 gcagtggaacttttgcggaccgtgcaagcgg 
 
screen PUF3 KO 
cz6249 tataagatctgcatgcggtgaacggcctagtgatgt pHD2880 
TUT3 
RNAi_stemloop 
cz6250 tatagaattcgtcgacatcatccccctctttgcttt pHD2880 
TUT3 
RNAi_stemloop 
cz6251 tatcctcgagatgttcacatcggtgcctgtagctcc pHD2859 V5-TUT3 
cz6296 tatagagctcgtggttagcggaagtagcagtagtgcaag pHD2893 TAP-PUF3 
cz6297 tatacatatgcctatatacccaaaatgataccttaagtg pHD2893 TAP-PUF3 
cz6298 tataaagcttccatgtggactgtgcaggaggacgagtac pHD2893 TAP-PUF3 
cz6299 tatagggccccctttgccagctcgtaaacgtttccc pHD2893 TAP-PUF3 
cz6300 tatatctagagcaagctaaggtacttctcgacctttgc pHD2859 V5-TUT3 
cz6328 ttcttggttcaaaagctg 
 
PUF3 probe 
cz6329 tagcgtgattaccattcg 
 
PUF3 probe 
cz6330 acgcgggagggcctttcg 
 
TUT3 probe 
cz6331 tggactttttgcgctgcacag 
 
TUT3 probe 
cz6351 tataagatctgcatgccggacgataatgagcgaaat pHD2881 
PUF3 
RNAi_stemloop 
cz6352 tatagaattcgtcgaccctcagcaatttgcaaacag pHD2881 
PUF3 
RNAi_stemloop 
cz6382 taatccgcggacgcgtgggagaatataaagattc pHD2891 TRIBE_C-terminal 
cz6383 tatatctagacctatatacccaaaatgat pHD2891 TRIBE_C-terminal 
cz6384 tatagtcgacgcatgcatgtggactgtgcaggag pHD2891 V5-PUF3-ADAR 
cz6385 tatgaattcgccggagagcggttggtt pHD2891 V5-PUF3-ADAR 
cz6386 attgaattctgcaatatttcctacagtccaatggtggtgccacag pHD2891 TRIBE_C-terminal 
cz6387 tataagatcttcattcggcaagaccgaac pHD2891 TRIBE_C-terminal 
cz6388 aatctcgagtccgaattctccagatctactcccatggccaagtgt pHD2891 TRIBE_C-terminal 
cz6389 atatgggcccgggagtcgtggaaacact pHD2891 TRIBE_C-terminal 
cz6451 tatagggcccatgtggactgtgcaggaggac 
pHD2895 
and 
pHD2904 
PUF3 and PUF3-
myc 
cz6452 atatgttaactcagccggagagcggttgg 
pHD2895 
and 
pHD2894 
PUF3 and myc-
PUF3 
cz6453 atatgttaacgccggagagcggttgg pHD2904 PUF3-myc 
cz6482 atagggcccTTatgtggactgtgcaggagg pHD2894 myc-PUF3 
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cz6728 tataagatctgcatgcgctgaatcaagcgcg pHD2952 
TbEIF4E1 
RNAi_stemloop 
cz6729 tatagaattcgtcgacttacagtagtgaagcatcgc pHD2952 
TbEIF4E1 
RNAi_stemloop 
cz6749 tatagggcccatgatggctgaatcaag pHD2953 
Tethering 
TbEIF4E1 
cz6750 tatagttaacggccttgctagcgccatg pHD2953 
Tethering 
TbEIF4E1 
 
36 
 
 
2.16 Plasmids used and their maps 
Enzymes used to linearize the DNA before transfection are written in red. Primers used for 
cloning genes/gene fragments are prefixed with the letters “cz”. 
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3.0 Results 
 
PART 1 – EIF4E1 interacting protein Tb4EIP 
 
3.1 Tb4EIP is located in the cytosol 
Pleomorphic bloodstream cells lacking endogenous Tb4EIP (generated by Johana Braun) and 
ectopically expressing a tetracycline inducible Tb4EIP with a myc tag on the C-terminal end, 
were used to determine the cellular location of Tb4EIP by immunofluorescence microscopy. 
Procyclic cells were examined 3 days after differentiating the bloodstream cells (detailed in 
section 3.7) in the presence/absence of tetracycline. Cells were stained with anti-myc antibody 
(1:500, mouse) followed by anti-mouse secondary antibody (1:700) conjugated with Cy3 
fluorophore. Tb4EIP signal appeared with higher intensity from the cytosol though the signal in 
bloodstream forms was weaker relative to procyclic forms (Figure 3). Some signal was 
observed in control cells possibly because of marginal expression in the absence of 
tetracycline. Using TrypTag 163, an online resource that contains localization data of many 
proteins in T. brucei, Tb4EIP also appears in the cytosol but in granules. Since Tb4EIP is 
known to congregate in stress granules 164 it is possible that the cells used in the imaging 
were already stressed due to incubation in PBS during the live cell imaging. The results and 
those from TrypTag suggest that most Tb4EIP is in the cytosol. 
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Figure 3: Cellular localization of Tb4EIP in bloodstream and procyclic forms. (A) Location of 
Tb4EIP in bloodstream cells. Bloodstream cells induced/non-induced (Tet+/-) with tetracycline 
to express 4EIP-myc for 24 hrs, were stained for microscopy. DAPI represents the nucleus 
and kinetoplast DNA staining, Cy3 represents Tb4EIP-myc and DIC is the differential 
interference contrast. The Cy3 signal was very faint and barely visible (B) Location of Tb4EIP 
in procyclic cells. Three day old procyclic cell growing in the presence/absence of tetracycline 
were processed similar as in (A). Bar =20µM 
 
3.2 Truncated Tb4EIP does not interact with TbEIF4E1 in vivo 
Preliminary data showed that Tb4EIP interacts with TbEIF4E1 and not with any of the other 
five eIF4Es. The interaction had been demonstrated in a yeast-two hybrid (Y2H) assay and in 
bloodstream forms by co-immunoprecipitation (co-IP). Tb4EIP-TbEIF4E1 interaction was 
however lost when Tb4EIP lacking the canonical eIF4E binding motif (YXXXXLΦ) was used in 
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Y2H assay, showing that the motif is required for binding in yeast. Structural analysis of 
Leishmania protein versions showed a second helical (non-canonical) motif that increases the 
Lm4EIP-LmEIF4E1 binding affinity 9-fold 151. To check this result for trypanosome cell lysates, 
and whether the second motif is sufficient for binding in vivo, I used co-IP. The truncated 
Tb4EIP (TbΔN4EIP) was not able to pull down TbEIF4E1 whereas the full-length protein was 
co-precipitated (Figure 4A). This confirmed that the N-terminal canonical motif is required for 
interaction in vivo even when the second motif is present. 
In Leishmania, Lm4EIP-LmEIF4E1 interaction was present in the insect stage promastigotes 
and not detected in vertebrate stage amastigotes 150. To test whether the Tb4EIP-TbEIF4E1 
interaction is also developmentally regulated in trypanosomes, bloodstream forms were 
differentiated to procyclic forms and maintained for 4 weeks as procyclic forms before 
performing a co-IP. In contrast to Leishmania 150, Tb4EIP-TbEIF4E1 interaction was 
detectable for both parasite forms (Figure 4B). Consistently, TbΔN4EIP in procyclic forms was 
also unable to pull down TbEIF4E1 confirming that the canonical N-terminal motif is essential 
for binding in both parasite forms.  
 
Figure 4: Interaction of truncated Tb4EIP with TbEIF4E1 in bloodstream and procyclic forms. 
(A) Western blot showing presence of TbEIF4E1 in Tb4EIP precipitates. Cells co-expressing a 
V5-tagged TbEIF4E1 (V5-4E1) and myc tagged Tb4EIP (4EIP-myc) were induced for 24 hrs 
to express Tb4EIP. λN is a short peptide that can bind boxB mRNA sequences, but is not 
relevant here. ΔN4EIP is the truncated Tb4EIP lacking the canonical motif YXXXXLΦ required 
for binding to TbEIF4E1. A cell line lacking Tb4EIP-myc was used as a negative control while 
those expressing full length Tb4EIP were used as positive controls. ‘In’ is input (~5×106 cells), 
‘U’ is unbound (~5×106 cells) and ‘B’ is bound (~1×108 cells). The lower panel is an over-
exposed version of the upper panel that shows myc expression in the inputs. A non-specific 
42 
 
band appears below 4EIP-myc. (B) Western blot showing a similar experiment as (A) but 
using procyclic cells. 
Interactions in yeast were therefore similar to the interactions detected in trypanosomes by the 
co-IP. The results collectively show that Tb4EIP-TbEIF4E1 interaction depends on the 
canonical YXXXXLΦ motif and that the interaction is not developmentally regulated, at least in 
bloodstream and procyclic forms. 
 
3.3 TbEIF4E1 requires Tb4EIP for gene suppression 
Both Tb4EIP and TbEIF4E1 are strong repressors of expression when tethered to a reporter 
gene 78. Tb4EIP lacking the canonical TbEIF4E1 binding motif and which does not interact 
with TbEIF4E1 remained repressive, implying that repression by Tb4EIP does not require 
binding of TbEIF4E1, though it may be required in vivo to enhance binding or stabilize 
Tb4EIP. The C-terminal end of Tb4EIP was also found to be sufficient for repression152. To 
test the reverse hypothesis i.e. whether repression by TbEIF4E1 requires Tb4EIP, I tethered 
TbEIF4E1 to CAT (chloramphenicol acetyl transferase) mRNA in cells lacking Tb4EIP (see 
knockout experiment in section 3.4). Interestingly, TbEIF4E1 does not repress the CAT 
reporter expression both at mRNA and at protein level (Figure 5).  
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Figure 5: Gene repression by TbEIF4E1 requires Tb4EIP. (A) CAT (chloramphenicol 
acetyltransferase) activity in the presence/absence of Tb4EIP and Western blot showing 
expression of TbEIF4E1-myc. TbEIF4E1-myc tagged with a λN peptide on the N-terminal end 
(pHD2953) was transfected into cells lacking 4EIP and constitutively expressing a CAT gene. 
TbEIF4E1 was tethered to the 3’UTR of the CAT gene which contains a boxB sequence 
capable of binding λN peptide of TbEIF4E1-myc, by inducing with tetracycline for 24 hrs. Cell 
lines lacking TbEIF4E1 with the λN peptide served as controls. Cell lysates were used for 
measuring CAT activity, for Western blotting and for northern blotting. (B) A northern blot and 
the quantification of the CAT mRNA relative to the rRNA. 
Lysates from the tethering cell line lacking Tb4EIP had similar CAT activity to those from 
control cell lines despite leaky expression of 4E1-myc in the absence of tetracycline. A similar 
repressive trend was observed at the mRNA level; TbEIF4E1 was only repressive in the 
presence of Tb4EIP. Therefore tethered TbEIF4E1 requires Tb4EIP to repress expression 
and it is not a repressor by itself. A similar scenario has been reported in Drosophila Cup 135, 
and mammalian 4E-T 140 and GRB10-interacting GYF GIGFY2 141,142. Mammalian eIF4E 
homologous protein 4EHP is repressive only when interacting with GIGYF2. It is therefore 
thought that 4EHP prevents translation by competing with eIF4E for the mRNA cap and 
repress expression by binding to the repressor GIGYF2 142. This could be a possible 
mechanism also for trypanosome Tb4EIP. The results therefore demonstrate that the 
repression activity of Tb4EIP-TbEIF4E1 complex is inherent to Tb4EIP. 
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3.4 Tb4EIP binds Terminal uridylyl transferase 3 
Repression activity of Tb4EIP could be mediated by recruitment of the deadenylation complex 
and/or the degradation machinery. To determine the proteins that are recruited by 4EIP, 
immunoprecipitation assays were done by my colleagues using a myc-tagged version of 4EIP 
followed by mass spectrometry of the precipitate. In addition to TbEIF4E1, TUT3 (terminal 
uridylyl transferase 3) and MKT1-like were co-purified.  
First, I sought to validate Tb4EIP-TUT3 and Tb4EIP-MKT1-like interactions using a co-
immunoprecipitation assay (Figure 6). TUT3 was myc-tagged on the C-terminus (pHD2736) 
and MKT1-like V5-tagged on the N-terminus (pHD2730). By pulling down Tb4EIP, it was 
possible to detect TUT3 in the precipitate (Figure 6A) and likewise, pulling down TUT3 co-
purified Tb4EIP (Figure 6B). Further, Tb4EIP-TUT3 interaction was confirmed in the presence 
of RNase A to abolish possible RNA dependent interactions (Figure 6A, right panel). However 
Tb4EIP did not co-purify with MKT1-like (Figure 6C). The results indicated that Tb4EIP binds 
TUT3 in vivo in an RNA independent fashion but does not bind MKT1-like. Sections 3.8 – 3.10 
show preliminary studies conducted on TUT3. 
Subsequent tandem affinity purifications of Tb4EIP done by my colleague Monica Terrao 
could not detect TUT3 or MKT1-like on mass spectrometry. This was not surprising 
considering the tiny amount of protein co-purified using either Tb4EIP or TUT3. Such weak 
interactions may not survive a tandem purification. 
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Figure 6: Tb4EIP interacts with TUT3 but not with MKT1-like. Western blots showing 
presence of Tb4EIP, MKT1-like and TUT3 in respective pull-downs. Cells expressing V5/myc 
tagged versions of Tb4EIP, TUT3 or MKT1-like were subjected to a co-immunoprecipitation 
assay. Pull-downs were done using anti-V5 or anti-myc agarose beads using cells lacking V5 
or myc accordingly as controls. Also pull-downs were done in the presence or absence of 
RNase A to control for RNA dependent interactions. ‘In’ is input (~5×106 cells), ‘U’ is unbound 
(~5×106 cells) and ‘B’ is bound (~1×108 cells).  (A) shows test for Tb4EIP-TUT3 interaction 
using anti-V5 agarose beads in the presence and absence of RNase A. (B) is the anti-myc 
pull-down similar to (A). (C) shows test for Tb4EIP-MKT1-like interaction using anti-V5 
agarose beads in the absence of RNase A. Aldolase was used as a loading control. 
 
3.5 Tb4EIP is not essential for survival of bloodstream and procyclic forms 
By interacting with a translation initiation factor, it is conceivable that Tb4EIP plays a role in 
translation regulation and therefore its role is presumably indispensable. Previously, depletion 
of Tb4EIP by RNAi was attempted but some protein expression persisted with a marginal 
growth defect 152. A complete deletion was therefore attempted in both bloodstream (done by 
a student on rotation, Johanna Braun) and procyclic forms by sequential replacement of both 
alleles of Tb4EIP by homologous recombination with drug resistance cassettes (pHD2797 and 
pHD2898). Genomic DNA was extracted from clones growing on blasticidin and puromycin 
and a polymerase chain reaction (PCR) done to detect Tb4EIP DNA (Figure 7).  
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Figure 7: 4EIP is not essential for survival of T. brucei. (A) PCR to detect 4EIP and drug 
resistance genes. DNA was extracted from candidate double knockout (DKO) clones, wild-
type (WT) or single knockout (SKO) clones and used as template in a PCR assay targeting 
4EIP, puromycin N-acetyltransferase (PAC) and blasticidin-S deaminase (BSD). Primers are 
prefixed with “cz” and the region they target is indicated by an arrowhead. Open reading 
frames of genes are shaded green while fragments of untranslated regions used for cloning 
are shaded blue. (B) Growth curves of DKO clones in comparison with WT and SKO. Error 
bars represent standard deviation of three independent experiments. This was done by 
Johanna Braun. (C) Growth curves of DKO clones inducibly expressing Tb4EIP from an 
ectopic locus (4EIP add-back, AB). (D) Growth curves of WT, double knockout (KO) and AB 
procyclic cells. Error bars represent standard deviation. The add-back represents one 
experiment. (E) Doubling times of similar cell lines in B and C as well as an AB expressing a 
truncated Tb4EIP lacking the N-terminal canonical motif for binding TbEIF4E1. Two 
47 
 
experiments were done approximately 8 weeks apart. Graph was drawn by Christine Clayton. 
(F) Western blots showing inducible expression of 4EIP-myc and ΔN4EIP-myc in the DKO. 
The double knockout (DKO) clones tested had no detectable Tb4EIP DNA and instead had 
both puromycin N-acetyltransferase (PAC) and blasticidin-S deaminase (BSD) in the Tb4EIP 
locus (Figure 7A). Lister 427 procyclic forms however had faint bands of Tb4EIP despite 
having both BSD and PAC correctly integrated. This could possibly be explained by the 
presence of a small population that is growing on both selection drugs but are not DKO. The 
Lister 427 cells were not used for any further analyses. Knockout was nevertheless successful 
in the pleomorphic EATRO1125 cells indicating that Tb4EIP is not required for survival of 
bloodstream and procyclic forms. 
To determine whether the DKO cells had a growth defect, cells densities of EATRO1125 
bloodstream cells were monitored daily in media without selecting drugs (Figure 7B). Tb4EIP 
knockout mutants had a slight but reproducible growth defect (Figure 7B) which could be 
rescued by re-expression of Tb4EIP from an ectopic locus (Figure 7C and D). While 
generating the add-back clones (with full-length and truncated Tb4EIP) which took 
approximately 8 weeks, the DKO clones which were meanwhile maintained in culture had 
strangely recovered from their growth defect (Figure 7E, Experiment 2). Expression of the 
ectopic copy of Tb4EIP also caused an increase in division times compared to the non-
induced counterparts. This could be attributed to an adaptation mechanism to life without 
Tb4EIP and over-expression would therefore cause a growth defect associated with reverting 
to life with Tb4EIP. It is also conceivable that excess of Tb4EIP could cause non-specific 
targeting hence affect cell growth. Collectively, the results indicate that Tb4EIP is not required 
for survival of bloodstream and procyclic forms of the parasite but is probably required for 
normal growth in both bloodstream and procyclic forms.  
 
3.6 4EIP is required for translation repression during stumpy formation 
Bloodstream forms divide logarithmically as slender forms and stop when high density is 
attained; they become arrested at G1/G0 phase and transform to stumpy forms which is the 
transmissible stage pre-adapted for differentiation. In the midgut of the insect the stumpy 
forms differentiate further to procyclic forms. Differentiation to stumpy forms is marked by 
global suppression of gene expression with synthesis of select proteins including 
mitochondrial enzymes and proteins associated with differentiation (PAD) 23. Since tethered 
Tb4EIP represses expression of a reporter (see Figure 5), I tested whether Tb4EIP plays a 
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role in translation repression during stumpy formation. Cells were grown to high densities in 
methyl-cellulose-containing media and monitored for incorporation of methionine at different 
time-points during stumpy formation.  
At maximum density ~2.5×106 cells/ml which corresponds to the onset of stumpy formation, 
the WT cells had reduced incorporation of methionine, which is the normal suppression of 
translation during stumpy formation. Interestingly, the Tb4EIP KO cells continued to 
incorporate significantly more methionine even at 48 hrs when their density corresponded to 
that of stumpy forms. Further, they did not express the stumpy marker PAD1. Tb4EIP add-
back (AB) reverted the increased methionine incorporation showing that the defective 
incorporation was caused by absence of Tb4EIP. The effect of the un-induced AB cells did not 
exactly reproduce the effect of KO cells probably because of leaky expression, and were 
therefore referred to as AB± (Figure 8B). 
In addition, the densities of cells declined at different rates. Tb4EIP KO cell densities declined 
similar to WT cells but the complemented KO (add-back, AB) cells significantly remained at 
higher densities for longer (Figure 8A). This suggests that excess Tb4EIP promotes cell 
survival at high densities. 
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Figure 8: Tb4EIP is required for translation repression during stumpy formation. (A) Densities 
of cells during stumpy formation. The 0hr time point represent five independent experiments, 
the 36 and 48 hr time points represent eight independent experiments and the 60 hr time point 
represent three experiments. Means and standard deviations are plotted. The box plot on the 
right depicts cell densities at the 48 hr time point. Boxes represent quartiles, the middle lines 
are medians and the whiskers are minimum and maximum values. (B) A representative 
coomassie stained protein gel and its autoradiograph of cell lysates from (A). The graph on 
the right represents relative quantities of incorporated methionine. Cells were collected at 
each time point shown in (A) and pulsed with methionine [35S] for 20 min following a one hour 
methionine starvation. Cell lysates were analysed by SDS-PAGE and autoradiography. ** 
represent student test p-value P<0.01 and * represent P<0.05. The graph was made by 
Christine Clayton. The expression of AB 4EIP-myc, PAD1 and RBP10 are shown in the 
Western blot below the graph. The ribosomal protein S9 and Ponceau stain served as loading 
(C) Northern blot showing quantity of mRNA during stumpy formation. Cells were collected at 
each time point shown in (A) for RNA extraction. Equal amount of RNA were used per sample 
and analysed by Northern blotting, probed for spliced leader (SL) and tubulin that are shown 
by arrow-heads. 
The inability to repress translation could be as a result of higher mRNA content in the KO 
cells. To test this hypothesis, total RNA was obtained from cells during stumpy formation. All 
trypanosome mRNAs have a SL (spliced leader) at the 5’ end 3. Messenger RNA content can 
therefore be estimated using a probe against the SL on a northern blot. Total RNA was 
extracted from cells at different densities during stumpy formation and analysed on a northern 
blot. However, sufficient intact RNA could not be obtained especially from cells after high 
density (Figure 8C). This could probably be caused by high concentration of RNases from 
dying cells in the decline phase during stumpy formation. Nevertheless, there was no 
detectable difference in the SL signal between samples at 0 hr and at 36 hr. The signal of 
tubulin mRNA which is abundant in cells, was also minimal or completely undetectable in the 
dense cells. The SL RNA (Figure 8C) was however detected in increasing amounts as the 
cells differentiated to stumpy. Interestingly, there was an accumulation of small RNAs 
demonstrated by the ethidium bromide stain, but the reason for this is unknown. Technical 
challenges could not be ruled out because of lengthy sample collection from the semi-solid 
media (see materials and methods, 2.1). The northern blot was therefore not interpretable at 
the moment. 
 
3.7 Tb4EIP is required for differentiation to procyclic forms 
Tb4EIP KO cells do not express the stumpy marker PAD1 when put to differentiate. This is 
despite them growing to high densities, which is a trigger for stumpy formation - a mechanism 
that involves stumpy induction factor (SIF) 22,165. In addition, Tb4EIP KO cells are unable to 
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repress translation at high densities. These cells could therefore be defective in stumpy 
formation and likely unable to differentiate to procyclic forms. To test this, the cells were 
treated with 10µM of the cAMP analog, 8-pCPT-2’-O-Me-cAMP, for 36 hrs or grown to high 
density in semi-solid media (see section 3.6) to make stumpy forms, and then treated with 
6mM cis-aconitate (CA) which induces differentiation of stumpy forms to the insect stage 
procyclic forms. EP procyclin is the surface protein in procyclic cells and is therefore a 
convenient marker for monitoring differentiation to procyclic forms. WT cells expressed EP 
already at 6 hrs after inducing differentiation whereas in KO cells, only small amounts of EP 
were detectable at 24 hrs (Figure 9A). 
 
Figure 9: Differentiation of stumpy to procyclic forms. (A) Western blots showing presence of 
EP during differentiation. Slender cells were grown to high density or treated with 10µM cAMP 
analog (8-pCPT-2’-O-Me-cAMP) for 36 hrs (indicated by *) to make stumpy forms (0 hr) and 
treated with 6mM cis aconitate for 24 hr to differentiate to procyclic forms. Cells were collected 
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at various time points during differentiation and analysed by Western blotting. Cells used are 
WT; wild type, KO; 4EIP knockout, AB; KO with inducible expression of 4EIP-myc, ΔN; KO 
with inducible expression of ΔN4EIP-myc. Procyclins EP/GPEET were used to monitor 
differentiation, PAD1 indicate stumpy forms while S9 indicate loading. (B) Growth curve of 
cells from (A) 24 hrs into differentiation to procyclic cells. (C) Cells at 24 hrs after cis-aconitate 
were stained with DAPI and the kinetoplast repositioning quantified in comparison to 
bloodstream (BS) and procyclic (PC) forms. The cell metrics and box-plots were done by 
Christine Clayton because the slides needed to be read blind. The first Western blot was done 
by a rotation student, Johanna Braun. 
This defect could be rescued by ectopic expression of Tb4EIP. In addition a truncated Tb4EIP 
(ΔN4EIP) that does not bind TbEIF4E1 could similarly rescue the defect in Tb4EIP KO 
indicating that Tb4EIP-TbEIF4E1 interaction is not essential for normal differentiation (Figure 
9A, middle and lower panel). 
Further, cell numbers were monitored 24 hr after differentiation (Figure 9B). WT cells grew 
exponentially as procyclic forms while the KO complement cells (AB and ΔN) grew much 
slower. The KO cells however did not grow and eventually died between 2-3 days after 
differentiation. This is consistent with the KO cells inability to form viable stumpy forms and as 
a result do not differentiate further to procyclic forms, thus highlighting the need for Tb4EIP in 
stumpy formation. 
During differentiation to procyclic forms, the kinetoplast DNA migrates to a position such that 
the distance between the nucleus and kinetoplast is approximately equal to the one from the 
posterior edge to the kinetoplast, a phenomenon called kinetoplast repositioning 166. 
Bloodstream cells therefore have a k-end/K-N ratio less than one while procyclic cells have 
ratios higher than one. The K-end/K-N ratio for all the newly differentiated cells (3 days old) 
were higher than that of bloodstream cells indicating successful repositioning of the 
kinetoplast and a sign of procyclic life (Figure 9C). The ratios were however lower than in late 
procyclic forms a phenomenon already seen elsewhere in early procyclic forms 45. There was 
however no difference between the KO and AB/ΔN cells, though the WT cells had a slightly 
higher ratio.  
Together, the results indicate that Tb4EIP is required for differentiation at least to repress 
gene expression during stumpy formation. The interaction with TbEIF4E1 is not required for 
differentiation and possibly for translation repression since TbΔN4EIP does not interact with 
TbEIF4E1 and is still capable of repressing expression of a reporter and of rescuing 
differentiation defect of Tb4EIP KO cells. Tb4EIP is therefore required for normal 
differentiation to stumpy and procyclic forms. 
53 
 
3.8 TUT3 is not essential for survival of bloodstream trypanosomes 
Terminal uridylyl transferases (TUT) add uridine residues at the end of mRNA. In mammals 
TUT are implicated in mRNA degradation. TUT4 and TUT7 uridylate mRNA with short poly(A) 
tail and the LSM1-7 complex binds the short U-tail and facilitate decapping by DCP1/2 
complex, or the short U-tail is recognised by DIS3L2 or the exosome that degrades the mRNA 
in the 3’-5’ direction or in the 5’-3’ by XRN1 167. In trypanosomes, uridylation has been 
detected in GPEET mRNA in early procyclic forms where GPEET is gradually repressed and 
replaced by EP 168. This could implicate TUT3 in uridylation of GPEET mRNA for degradation 
in early procyclic. I have earlier demonstrated that TUT3 and Tb4EIP are binding partners and 
therefore are likely to participate in similar pathways. According to a poly (A)-mRNA-proteome 
screen, TUT3 does not associate with mRNA 78. It is neither a repressor nor an activator of 
gene expression 84 suggesting its need for Tb4EIP form mRNA binding. 
To obtain a first impression of its role, I attempted RNAi of TUT3 in bloodstream and procyclic 
cells. A single allele of TUT3 was V5 tagged (plasmid pHD 2859) and a plasmid for RNAi 
(plasmid pHD 2880) expressed ectopically under the control of tetracycline repressor. RNAi 
was induced every 24 hrs and cell densities determined. Some V5 tagged protein was still 
detectable after 5 days of RNAi in both bloodstream and procyclic forms thus depletion was 
not entirely successful (Figure 10A). Further, the cells had no detectable growth defect in both 
parasite forms compared to WT cells probably because the remaining protein after RNAi was 
sufficient for normal growth. 
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Figure 10: TUT3 is not essential for growth and survival. (A) Growth curve of cells depleted or 
lacking TUT3 and Western blot showing expression of TUT3. For RNAi, cells were induced 
with tetracycline every 24 hrs and their cell density determined. Cells were collected at each 
time-point for Western blot to monitor expression of V5-TUT3. Ribosome subunit S9 or a non-
specific band were used as a loading control. Left panel represents growth curve for two 
monomorphic bloodstream (BF) clones marked with squares and circles respectively while the 
WT is marked with diamond shape. Middle panel represents average growth curve of three 
pleomorphic procyclic (PC) clones induced (+) or non-induced (-) for RNAi. Right panel 
represents growth curve for three TUT3 knockout clones (dKO) in comparison to WT and 
single knockout (sKO). (B) Southern blotting and PCR to detect presence of TUT3. Wild-type 
(WT), sKO containing blasticidin-S deaminase (BSD), sKO containing puromycin 
acetyltransferase (PAC) and candidate dKO cells were used. Genomic DNA obtained from 
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these cells was digested with Nsil which cleaves TUT3 gene into three as shown in the upper 
panel. The digested DNA was separated in an ethidium bromide stained gel and transferred to 
a nylon membrane for southern blotting. A probe targeting the C-terminal end and another 
targeting the whole TUT3 coding sequence were used as indicated in the middle panel. The 
DNA used for southern blotting was used for PCR using the primers prefixed with “cz” as 
indicated in the cartoon. Primers to amplify PUF3 were included in the reactions as a loading 
control. True KO clones are labelled in red. 
I therefore attempted a gene knockout by replacing both TUT3 alleles with genes encoding 
drug resistance in pleomorphic bloodstream cells (Figure 10B). DNA was extracted from 
clones that were growing on both drugs corresponding to the two drug resistance genes used 
for the knockout, and analysed by PCR and southern blotting. The southern blot was probed 
using a fragment and the whole coding sequence of TUT3. Half of the KO clones tested were 
positive TUT3 KO cells as they gave no signal in both the PCR and southern blot.  
To find out whether the knockout cells had any growth disadvantage, cell densities of three 
knockout clones were monitored for five days and compared to the WT. The TUT3 KO cells 
grew similar to WT cells (Figure 10A, right panel). These results collectively demonstrate that 
TUT3 is not essential for growth and survival of T. brucei as bloodstream or procyclic forms. 
 
3.9 TUT3 is not required for differentiation to procyclic forms 
Since Tb4EIP is essential for normal differentiation, its binding partner TUT3 is presumably 
required in differentiation. I therefore attempted to differentiate the cells. TUT3 knockdown and 
knockout bloodstream cells were induced for differentiation by treatment with 6mM cis-
aconitate and reduction of temperature to 27°C, then monitored for the expression of the 
surface coat protein, EP procyclin. Depletion of TUT3 in pleomorphic forms was more efficient 
than in monomorphic strains  as observed at the initial hours of differentiation (compare Figure 
10A, left panel and Figure 11, middle panel). The depletion efficiency decreased as the cells 
became procyclic. Growth kinetics during differentiation remained similar to WT cells (Figure 
11, left panel). However, contrary to Tb4EIP, there was no defect in the expression of EP 
procyclin during differentiation.  
TUT3 is therefore not required for differentiation like its binding partner Tb4EIP. Preliminary 
results from our lab suggest that TbEIF4E1 is also not required during differentiation, hitherto 
positioning Tb4EIP at the centre of the pathway among its binding partners. 
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Figure 11: Differentiation of bloodstream to procyclic forms depleted/lacking TUT3. Left panel 
is a growth curve of pleomorphic cells (EATRO 1125) induced (Tet+) or uninduced (Tet-) for 
TUT3 depletion by RNAi and treated with 6mM cis-aconitate and 27°C to induce 
differentiation. In the middle panel, expression of EP was monitored by Western blot during 
differentiation. Cells lacking the RNAi construct were included as control. S9 represents 
loading. The right panel represents expression of EP in differentiating monomorphic cells 
(Lister 427) with (+) or without (-) TUT3 i.e. TUT3 KO. These were put to differentiate as in the 
middle panel. 
 
3.10 TUT3 is located in the cytosol 
Trypanosoma brucei has five terminal uridylyl transferases mostly localized in the 
mitochondria and involved in RNA editing 169. Two of these TUT3 and 4 are however thought 
to be cytosolic 170. To determine the cell localization of TUT3, cells expressing TUT3 with a C-
terminal myc tag (plasmid pHD 2736) were analysed by immunofluorescence microscopy. 
Tryparedoxin peroxidase (TxNPx) and aldolase were used as cytoplasmic and glycosomal 
controls respectively. TUT3 signal appeared to co-localise with both aldolase and TxNPx 
signals (Figure 12A and B).  
To make a distinction, cell fractionation using digitonin was done whereby serial 
concentrations of digitonin were used to rupture cell membranes so that proteins in intact 
organelles remain in the pellet after centrifugation. The migration of TUT3 from the pellet to 
the supernatant relative to aldolase was monitored using a Western blot (Figure 12C). TUT3 
was detectable in the supernatant at lower digitonin concentrations similar to the cytosolic 
control TxNPx. Meanwhile, aldolase migrates to the supernatant at much higher 
concentrations. This implies that TUT3 and aldolase are in different locations in the cell and 
TUT3 is not in the glycosomes. Collectively the immunofluorescence and the cell fractionation 
assays demonstrate that TUT3 is cytosolic. 
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Figure 12: Localisation of TUT3. (A) Immunofluorescence images showing staining for TUT3 
and other proteins. Bloodstream cells expressing an inducible myc tagged TUT3 from an 
ectopic loci (pHD2736) were stained with anti-TxNPx (rabbit-1:1000) and anti-myc (mouse-
1:500) followed by corresponding secondary antibodies with fluorophore (anti-rabbit Alexa488-
1:700, anti-mouse Cy3-1:700). (B) Cells were treated as in (A) but using anti-aldolase (rabbit-
1:1000). DIC is the differential interference contrast. DAPI was used for staining DNA. The 
colours used are not necessarily the true colour of the fluorophore. (C) Western blots showing 
migration of proteins from pellets to supernatants. Cells similar to those in (A) were lysed 
using increasing concentrations of digitonin and organelle rupture was detected by the 
migration of the organelle’s proteins to the supernatant. Aldolase and tryparedoxin peroxidase 
were used as glycosome and cytosolic markers respectively. The amounts of digitonin (µg of 
digitonin/ mg of protein) are indicated on each lane. 
In summary, Tb4EIP and TUT3 interact, are cytosolic and are not essential for survival of 
growing bloodstream or procyclic forms of both monomorphic and pleomorphic cells. 
Nonetheless, cells lacking either of the two show different phenotypes during differentiation 
with Tb4EIP being essential during differentiation. TUT3 could play a peripheral function 
upstream in the pathway of Tb4EIP. 
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PART 2 – Pumilio domain protein PUF3 
 
3.11 PUF3 domain architecture and orthology 
Pumilio domain protein 3 (PUF3) orthologs are conserved across kinetoplastids and are 
almost always syntenic (TriTrypDB). To compare the domain architecture of PUF3, orthologs 
were obtained from trypanosomes (Trypanosoma brucei, T. vivax, T. congolense, T. theileri 
and T. cruzi), relative trypanosomatids (Leishmania major, Blechomonas ayalai and 
Endotrypanum monterogeii) and from a free living kinetoplastid Bodo saltans. 
Orthologs were virtually identical in the region with the PUF repeats (Figure 13A). The N-
terminal and the distal C-terminal ends were highly variable and this could imply different 
interactions and functions. A striking difference was observed between the free-living Bodo 
saltans and the parasitic trypanosomatids: the parasites have three major deletions flanking 
the PUF repeats region (Figure 13), a feature that could characterize loss or change of gene 
function and evolution to a dependent lifestyle similar to genome erosion in endosymbionts 171. 
T. congolense has a unique deletion in one of its PUF repeats and has only seven left. 
A cladogram using PUF3 protein sequences clusters the parasitic trypanosomatids into three 
(Figure 13B). The first clade consists of Bl. ayalai, L. major and E. monterogeii, which shares 
a deletion from amino acid 277-295 (Figure 13A). The second consists of T. cruzi and T. 
theileri while the third consists of the African trypanosomes - T. vivax, T. brucei and T. 
congolense.  
To get an overview of how T. brucei PUF proteins compare with respect to possible 
redundancy, their domain structures were predicted using SMART 156. The 11 PUF proteins of 
T. brucei have different domain architectures (Figure 13C). With the exception of PUF3, all the 
others have in addition, low complexity and coiled coil motifs. Apart from PUF4 and 6 which 
look similar, the others have unique domain arrangements. Further, only PUF2, 3, 4, and 6 
have the canonical 8 pumilio repeats. These dissimilarities suggest differences in function and 
a remote chance of functional redundancy. PUF4 and 6 could however share functions 
judging by their domain similarities.  
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Figure 13: Domain architecture and orthology of select kinetoplastid PUF3s. (A) Protein 
sequence alignment of PUF3. PUF3 protein sequences from Trypanosoma brucei, T. vivax, T. 
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congolense, T. theileri, T. cruzi, Leishmania major, Blechomonas ayalai, Endotrypanum 
monterogeii and from a free living kinetoplastid Bodo saltans were aligned using Clustal 
Omega (EMBL-EBI) with default settings. The shading highlights similarities. Red bars 
indicate the position of the PUF repeats relative to T. brucei. (B) A cladogram based on the 
same sequences in (A), drawn using Simple Phylogeny Tool (EMBL-EBI). (C) Domain 
organization of the 11 T. brucei PUF proteins. The domain organization was predicted using 
SMART tool. The horizontal lines represent the protein lengths drawn to scale.  
These observations suggest that PUF3 is unique in domain architecture from other PUF 
proteins in T. brucei and is likely to have a unique function. In addition, PUF3 appears to be 
highly conserved among the African trypanosomes and is likely to have a conserved function. 
 
3.12 PUF3 is localized in the cytosol 
Many proteins regulating gene expression at post-transcriptional level are localized in the 
cytosol. Most of the PUF proteins are cytosolic; exceptions are PUF7 and PUF10, which 
localise in the nucleolus and regulate GPEET mRNA and rRNA maturation 44,102. To determine 
the cellular location of PUF3, bloodstream cells with tagged versions of PUF3 (V5-PUF3: 
pHD2127 and PUF3-myc: pHD2904) were used in immunofluorescence microscopy and cell 
fractionation assay (Figure 14). 
 
Figure 14: PUF3 is localized in the cytoplasm. (A) Cell images showing the location of PUF3. 
One allele of PUF3 was V5-tagged on the N-terminus (pHD2127) and an RNAi construct 
(pHD2881) expressed ectopically. Cells were induced for RNAi for 24 hrs and processed for 
immunofluorescence microscopy. Anti-V5 antibody (1:500, mouse) and secondary antibody 
with Cy3 fluorophore (1:700, anti-mouse) were used. DNA was stained with DAPI. DIC is the 
differential interference contrast. (B) Cells expressing an inducible copy of PUF3 with a C-
terminal myc tag were induced for 24 hrs with tetracycline and lysed using increasing 
concentrations of digitonin. Organelle rupture was detected by the migration of the organellar 
proteins to the supernatant. PUF2 and aldolase were used as cytosolic and glycosomal 
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markers respectively. The amounts of digitonin (µg of digitonin/ mg of protein) are indicated on 
each lane. 
PUF3 appeared to be spread throughout the cytosol with no signal from the nucleus. A cell 
fractionation assay using digitonin was used to test whether PUF3 could be in the 
glycosomes. Migration of PUF3 from the pellet to the supernatant relative to aldolase and the 
cytosolic PUF2 was monitored during increased concentrations of digitonin. PUF3 migrates to 
the supernatant already at 1µg of digitonin/ mg protein similar to PUF2 whereas aldolase 
persists in the pellet and migrates at 28µg of digitonin/ mg protein treatment. Combined, these 
results indicate that PUF3 is cytosolic and is not detectable in the nucleus or glycosome. 
 
3.13 PUF3 is not essential for survival of trypanosomes 
To determine whether PUF3 is essential for cell growth, PUF3 was depleted by RNA 
interference (RNAi) in bloodstream forms. (This initial work on PUF3 was done in the 
monomorphic Lister 427 strain.) Previous transcriptome and ribosome profiling data 172 
suggested that PUF3 is more expressed in bloodstream forms than in procyclic forms while a 
genome-wide RNAi screen suggested that PUF3 is likely to be essential in bloodstream forms 
173. RNAi was therefore attempted in bloodstream forms. 
One of the PUF3 alleles was tagged so as to express a fusion of V5-PUF3 (pHD 2127, made 
by Claudia Helbig) to enable detection of PUF3 protein. This cell line was transfected with a 
plasmid pHD2881 for PUF3 RNAi. The effectiveness of the knockdown was determined by 
detecting V5-PUF3 on a Western blot. 
RNAi was induced by addition of 100ng/ml of tetracycline to the growing culture while 
monitoring cell density every 24 hrs. Tetracycline was added daily while splitting the cells as 
required. In two clones tested, cells depleted of PUF3 grew similar to wild-type (WT) cells but 
with a marginal defect (Figure 15A) despite sufficient knockdown; no PUF3 could be detected 
after 24 hr of RNAi induction in both clones (Figure 15B). Though the amount of PUF3 
detected is theoretically half the total (i.e. only one allele was tagged), the RNAi targets 
products from both PUF3 alleles. However, it is possible that small undetectable amounts of 
PUF3 are sufficient for the cell growth and therefore complete knockout of PUF3 was 
attempted. 
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Figure 15: PUF3 is not essential for survival of monomorphic bloodstream forms. (A) Growth 
curve of two PUF3 RNAi clones induced (+)/ uninduced (-) with tetracycline. (B) Western blots 
showing the expression of a V5-tagged PUF3 in the cell lines in (A). (C) The upper panel 
represents the design of a restriction digest. Coding sequences of genes are represented by 
rectangular blocks and vertical double-strokes show restriction sites. Genomic DNA of cells 
selected for double knockout (transfected with plasmid pHD2851 and pHD2852) were 
digested with EcoRI (experiment i) or EcoNI and SacII (experiment ii). The digested DNA for 
wild-type (WT), single knockouts (BSD and PAC) and candidate knockout clones were 
analysed by southern blotting using probes targeting PUF3 (shown in upper panel) and TUT3 
as a loading control. ‘L’ is the molecular marker. (D) DNA from (C) were also used in a 
polymerase chain reaction using the primers shown (prefixed with “cz”). Double stroke lines 
represent the ends of the cloning fragment used for transfections. 
Wild-type bloodstream forms were sequentially transfected with linearized DNA from pHD 
2851 and pHD 2852 which encode puromycin N-acetyltransferase (PAC) and blasticidin S 
deaminase (BSD), both flanked with segments of PUF3 UTRs for in locus integration of the 
drug resistance cassettes while replacing PUF3 coding sequences. Knockout clones were 
selected using both puromycin and blasticidin. PCR using primers originating within and 
without the transfection DNA confirmed the absence of PUF3 and the presence of the drug 
resistance cassettes in place of PUF3 (Figure 15D). Mutations during gene replacement can 
occur at primer binding sites and result in a false negative PCR of PUF3. A southern blot was 
therefore done to detect PUF3 in its locus (experiment i) and elsewhere in the genome 
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(experiment ii). A radioactive probe detecting a PUF3 unique sequence was used to detect 
PUF3 on an autoradiograph (Figure 15C). Both Southern blotting and PCR confirmed the 
absence of PUF3 in the knockout (KO) clones confirming successful deletion of PUF3 from 
the genome and that PUF3 is not required for survival of the monomorphic bloodstream forms. 
A proteomic screen in differentiating trypanosomes 32 showed that PUF3 is 1.5 fold up-
regulated during differentiation and a genome-wide RNAi screen 173 suggested that 
bloodstream cells depleted of PUF3 were disadvantaged during differentiation. To get a more 
realistic effect of PUF3 requirements in differentiation, RNAi and knockout of PUF3 were 
attempted in a pleomorphic T. brucei strain (EATRO 1125), which are capable of 
differentiating to growing procyclic cells. This was done in a similar manner as in the 
monomorphic cells described earlier. Knockdown of PUF3 conferred a marginal growth defect 
reproducible as from the third day of depletion (Figure 16A). The un-induced cells also 
showed a slight growth defect that could result from poor regulation of RNAi in the absence of 
tetracycline (Figure 16B). However, a parental cell line lacking the RNAi plasmid did not show 
a different V5-PUF3 signal from the un-induced RNAi cells therefore excluding leaky 
regulation (see lane marked with # in Figure 16B). This comparison was however done only 
once. Other fitness costs due to genetic manipulation cannot be completely ruled out. 
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Figure 16: PUF3 is not essential for growth and survival of pleomorphic cells. (A) Growth 
curve of bloodstream cells induced for RNAi against PUF3 in triplicate. Tetracycline induction 
and splitting of cell cultures were done daily. (B) Western blots showing depletion of PUF3 in 
the three replicates in (A). Trypanothione reductase (TR) or ribosomal protein S9 were used 
as loading controls. Lane marked with ‘#’ indicate the parental cell line of the RNAi clones. (C) 
Southern blot to detect presence of PUF3. The upper panel represents the design of two 
southern blot experiments. Coding sequences of tandem genes are represented by 
rectangular blocks and vertical double-strokes show restriction sites. Genomic DNA of cells 
selected for double knockout (transfected with plasmid pHD2851 and pHD2852) were 
digested with EcoRI (experiment i) or EcoNI and SacII (experiment ii). (D) Polymerase chain 
reaction to test for PUF3 knockout. Genomic DNA from wild-type, single knockouts (BSD and 
PAC) and knockout clones from (C) were used in a polymerase chain reaction using the 
primers shown (prefixed with “cz”). Double stroke lines represent the ends of the cloning 
fragment used for transfections. (E) Growth curve of knockout cells and add-back (AB+/-) 
expressing un-tagged PUF3 in the presence/absence of tetracycline. 
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In contrast to the monomorphic cells, some protein could still be detected even after 4 days of 
RNAi indicating that the RNAi was not adequate. Knockout of PUF3 was therefore attempted. 
Just like in monomorphic cells, both PCR and southern blotting confirmed that PUF3 is not 
essential for survival of the bloodstream cells. Furthermore a growth curve of the KO mutants 
did not show any growth defect in contrast to those depleted of PUF3 by RNAi. This 
discrepancy can be as a result of adaptation by the PUF3 null stable cell lines. 
Because of the possible adaptation to life without PUF3, depletion by RNAi is short-term and 
may therefore be used to study the immediate effect of depleting PUF3 before adaptation 
mechanisms ensue. With this assumption, a transcriptome profile was done following 24 hr 
depletion of PUF3 by RNAi and fold changes compared between induced and un-induced 
samples (Fig 3).  
 
Figure 17: Transcriptome analysis of PUF3 depleted pleomorphic EATRO 1125 bloodstream 
cells. (A) Western blot to detect PUF3. RNA interference against PUF3 was induced for 24 
hours in duplicate and depletion confirmed by Western blotting. Ribosomal protein S9 served 
as a loading control. (B) Total RNA from cells in (A) was depleted of rRNAs and given for 
library preparation and sequencing. RNA reads that aligned to coding sequences were 
analysed by DEseq2 and fold changes represented on a scatter plot. 
Unexpectedly, only one gene (Tb927.9.10170) was differentially expressed at an adjusted P-
value <0.1, and such a result is probably not significant. The gene is annotated as an 
anaphase-promoting complex subunit 11 (APC11). This gene was modestly upregulated by 
1.5 fold. APC is an E3 ubiquitin ligase complex that ubiquitinates cell cycle regulators securin 
and cyclin B in mitosis for elimination, thus enabling cell cycle progression from metaphase to 
anaphase 174. APC11 is one of the ten core components of APC in T. brucei 175,176. Its 
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depletion by RNAi in either bloodstream or procyclic forms had no effect on the cell cycle 175 
possibly due to the RNAi inefficiency. Ideally, this transcriptome profiling data would highlight 
a category of genes that are upregulated/downregulated and provide a hint to the function of 
PUF3. With the repressive function of PUF3, APC11 could be a target of PUF3 during the cell 
cycle but given the lack of an obvious cellular phenotype when APC11 is depleted 176, it was 
not pursued further. 
Collectively, depletion of PUF3 by RNAi in bloodstream forms causes a slight growth defect 
that does not significantly alter the transcriptome, at least in pleomorphic cells. Its depletion 
and knockout in bloodstream forms had no effect on cell growth and survival. PUF3 could 
therefore be required in other life stages hence its role in differentiation was explored. 
 
3.14 PUF3 is required for normal differentiation of bloodstream forms 
To investigate whether PUF3 is required for differentiation of bloodstream to procyclic forms, 
PUF3 knockout (KO) cells were monitored for the formation of the glutamate-proline (EP) rich 
procyclin surface coat that is characteristic of procylic (insect midgut) forms. First, as a proof 
of concept and out of convenience, bloodstream monomorphic PUF3 KO cell lines were used 
in the differentiation experiments because they were readily available. Pleomorphic cells 
would give a more realistic outlook on matters differentiation. The KO cells were grown to high 
density (1.8-2×106 cells/ml), treated with 6mM cis-aconitate and let to grow at 27°C. Samples 
were collected at various time-points and examined for EP/GPEET procyclin on a Western 
blot (Figure 18). 
The KO cells showed a delay in synthesis of EP/GPEET procyclin. Traces of procyclins in the 
KO were visible after 24 hrs of differentiation. A PUF3 KO cell line complemented with PUF3 
(Add-back, AB) had a modest rescue of this defect compared to wild-type (WT). This defect 
has also been reported in cells lacking zinc finger protein ZC3H18 96 and Tb4EIP. Strangely, 
PUF3 with a C-terminal tag was unable to rescue the KO defect in multiple attempts (Figure 
18C). In addition, detection of N-terminal tagged version of PUF3 was unreliable possibly due 
to some technical challenge. Therefore AB clones were made with untagged PUF3, and 
expression was confirmed by Northern blotting (Figure 18B). 
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Figure 18: PUF3 is required for normal differentiation in monomorphic cells. (A) Western blots 
showing expression of EP/GPEET. Monomorphic bloodstream cells were grown to 1.8-2.0 
×106 cells/ml and differentiated to procyclic by adding 6mM cis-aconitate (CA) to the culture 
and growing at 27°C. The time shown in hours is time after CA treatment. EP/GPEET were 
used to monitor differentiation and S9 represents the load. (B) Northern blot showing inducible 
expression of PUF3 add-back (AB) in clones 1-4. Signal recognition particle SRP and rRNA 
represent load. (C) Western blot of an experiment conducted as in (A) but using AB clones 
expressing PUF3 that has a C-terminal myc tag. (D) Western blot analysis of putative AB 
clones 1-5 expressing PUF3 that contains N-terminal myc tag. (E) Expression of EP cells 
depleted of PUF3 by RNAi. RNAi was induced for 24 hr, and cells at ~1.8×106 cells/ml were 
differentiated by adding 6mM CA to the culture and growing at 27°C.   
The defect in differentiation was also observed when pleomorphic cells depleted of PUF3 by 
RNAi were put to differentiate to procyclic forms. Cells were grown in semi-solid media 
containing methyl cellulose and meanwhile RNAi of PUF3 was induced for 48 hrs before 
initiating cells differentiation to procyclic forms. PUF3 depleted cells showed a delayed 
expression of EP (Figure 19A). In addition, PAD1 (marker for stumpy forms) was 
conspicuously depleted in RNAi conditions compared to similarly treated non-induced and 
wild-type cells (Figure 19B and C). PAD1 seems to appear later at six hours into differentiation 
and disappears as expected between 12-24 hrs. Notably, over-expression (Figure 19D, see 
0hr) and RNAi (Figure 19B, see 6hr) are abolished in high density cells because both 
strategies are dependent on RNA polymerase I, which gets turned off. RNAi and over-
expression were therefore induced for 48 hrs prior to growth arrest. 
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Figure 19: Differentiation of PUF3 depleted and deleted pleomorphic bloodstream cells. (A) 
Expression of EP procyclin during differentiation of PUF3 RNAi. EATRO1125 bloodstream 
cells were induced for RNAi for 48 hours while overgrowing in methyl cellulose containing 
media. The resulting stumpy cells at a density ~106 cells/ml were differentiated by adding cis-
aconitate (CA) and let to grow at 27°C. ls: slender cells, WT; wild-type; +/-; PUF3 RNAi 
with/without tetracycline. V5 represents expression of V5-PUF3, Ponceau and S9 represents 
load. (B) A replica of the experiment in (A) but showing in addition, expression of PAD1 – the 
marker for stumpy forms. (C) Expression of PAD1 in PUF3 RNAi conditions. Stumpy cells 
were developed as in (A). Procyclic cells, PC, at a density of ~3×106 cells/ml and ls were 
included for comparison. V5 represents expression of V5-PUF3, RBP10 expression 
represents slender cells, S9 represents the load. (D) Expression of EP in PUF3 knockout (KO) 
cells and two add-back clones during differentiation from stumpy to procyclic forms. Stumpy 
cells were made by growing the cells to high densities in methyl cellulose containing media 
and collected for analysis at a density ~106 cells/ml. The add-back clones inducibly express 
PUF3 with a c-terminal myc tag. (E) Expression of PAD1 in stumpy cells obtained as in (D) for 
WT, PUF3 single knockout (sKO) and double knockout (KO) clones 1-4. 
Having obtained PUF3 knockout pleomorphic cells, the expression of EP was tested. 
Surprisingly, these cells as well as add-backs express EP procyclin without any defect (Figure 
19D). In addition, PUF3 KO cells express the stumpy marker PAD1 similar to WT and single 
knockout (sKO) cells (Figure 19E). This is in complete contrast to the effect observed with 
depletion of PUF3 by RNAi and those from experiments using monomorphic cells. Depletion 
of ZC3H18 also delays EP expression and in contrast to PUF3, the defect persisted even in 
the ZC3H18 knockout EATRO1125 cell lines 96. These result could be caused by adaptation 
of the cells to life without PUF3 similar to adaptation already observed with the absence of 
defective growth in KO cells in contrast to cells depleted of PUF3 by RNAi (Figure 16). In 
69 
 
addition, the KO cells were capable of expressing PAD1 contrasting PUF3 depleted cells. A 
summary of the conditions that cause a defect in PAD1 and procyclin expression is shown in 
Table 2 
Table 2: Comparison of the effect of PUF3 depletion/deletion on expression of EP/PAD1 in 
monomorphic and pleomorphic cells 
 Monomorphic cells Pleomorphic cells 
WT Normal EP Normal EP and PAD1 
RNAi + Delayed EP Delayed EP and PAD1 
RNAi - Normal EP Normal EP and PAD1 
KO EP delayed Normal EP and PAD1 
AB + Normal EP Normal EP and PAD1 
AB - EP delayed Normal EP and PAD1 
 
Collectively, the results suggest that normally, bloodstream cells require PUF3 for normal 
differentiation kinetics. The absence of PUF3 in the short term (by RNAi) caused a delay in 
progression of differentiation. In contrast, complete knockout of PUF3 in pleomorphic cells did 
not stall differentiation, possibly because of some adaptation mechanism absent in 
monomorphic cells. I therefore sought to determine the converse; the effect of over-
expressing PUF3 in procyclic forms. 
 
3.15 Over-expression of PUF3 is lethal to procyclic cells  
The effect of over-expressing PUF3 was tested during differentiation of bloodstream to early 
procyclic forms and further as late procyclic forms. PUF3 add-back (AB) cells were generated 
from the pleomorphic PUF3 knockout (KO) bloodstream cells and these expressed an 
inducible PUF3 under the control of a RNA polymerase I promotor, and was therefore 
expected to be over-expressed in the presence of tetracycline. Since the AB cells expressed 
untagged PUF3, and an antibody against PUF3 was unavailable, the inducible expression 
could not be confirmed by Western blotting. Nonetheless, KO and AB cells were differentiated 
from slender/stumpy to procyclic cells. Bloodstream AB cells were grown for 24 hrs (slender) 
or 48 hrs (stumpy) in tetracycline prior to differentiation. After differentiation, both KO and AB 
cell cultures without tetracycline grew to high densities but surprisingly, add-back cells over-
expressing PUF3 had stunted growth and eventually died (Figure 20A and B). Cells 
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differentiated from slender cells started to divide from the third day while those differentiated 
from stumpy forms started dividing immediately on the first day in procyclic media (MEM) 
confirming that differentiation from stumpy forms is more efficient than from slender forms. 
The time point for cell division of KO and non-induced AB cells appeared to coincide with the 
density-decline time point of cells over-expressing PUF3. These results indicated a growth 
disadvantage for procyclic cells that supposedly over-express PUF3. 
To determine whether this defect was persistent in late procyclic cells, the early procyclic cells 
were grown in procyclic conditions for over 4 weeks and their growth kinetics monitored daily. 
The cells grew at a similar rate for 2-3 days and the AB over-expressing PUF3 stopped 
dividing. Wild-type (WT) cells grow to much higher densities indicating that procyclic cells 
lacking PUF3 also have a growth defect (Figure 20C). 
 
Figure 20: Growth curves of pleomorphic cells over-expressing PUF3. (A) Growth curve of 
slender bloodstream cells differentiating to procyclic forms. Slender cells were treated 
with/without tetracycline for 24 hrs and their densities set to 106 cells/ml, treated with 6mM cis-
aconitate (CA) and put to grow at 27°C – 0hr CA. After 24 hr in CA, the cells were transferred 
to MEM procyclic media at equal densities of 106 cells/ml. The double stroke lines indicate 
change of time scale. (B) Growth curve of stumpy cells differentiating to procyclic forms. 
Slender cells were grown with/without tetracycline to high densities in methyl cellulose 
containing media to form stumpy forms. These were transferred to methyl cellulose-free media 
at a density of 106 cells/ml, treated with 6mM CA and grown at 27°C. After 24 hr in CA, the 
cells were transferred to MEM procyclic media at equal densities of 106 cells/ml. (C) Growth 
curve of late procyclic cells. Differentiated bloodstream cells were grown for at least four 
weeks as procyclic forms before the experiment. Their density was monitored daily in the 
presence/absence of tetracycline. WT; wild-type, KO; PUF3 double knockout, PUF3+/-; KO 
with inducible PUF3 add-back in the presence/absence of tetracycline. 
Together, PUF3 seems to be essential for growth in procyclic forms but an excess of it is also 
lethal. Over-expression of PUF5 has also been reported to cause a growth defect in procyclic 
but not bloodstream trypanosomes 101. The authors proposed that over-expressed protein may 
outcompete other RBPs in binding some non-targets of low affinity. The similarities in PUF 
domains could allow a PUF protein to bind targets of other PUF proteins even just with low 
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affinity. Over-expression therefore could make up for the low affinity binding of a non-target 
and disrupt regulation. Elsewhere, it was impossible to obtain procyclic cells with over-
expressed-tagged version of ZC3H12, while procyclic cells over-expressing ZC3H13 
experienced impaired growth 94. In the same vein, over-expression of PUF3 could therefore 
affect other PUF targets and cause the growth defect observed. Though over-expression of 
PUF3 could not be demonstrated, the actin 3’UTR used in the over-expression plasmid 
(pHD2895) may disrupt regulation of PUF3 and favour mRNA stability or translation, hence 
over-expression. The northern blot in Figure 18B however shows roughly equal amounts of 
PUF3 mRNA for the WT and AB clones.  
 
3.16 Putative targets of PUF3 identified by RNA immunoprecipitation 
To determine the mRNAs that are bound by PUF3, RNA immunoprecipitation in tandem with 
RNAseq (RIP-seq) were carried out. Bloodstream pleomorphic cells with one PUF3 allele 
deleted and the remaining tagged on its N-terminus with a tandem affinity purification (TAP) 
tag were used. Cells were UV-irradiated, lysed and incubated with IgG beads. RNA was 
extracted from the unbound and the bound fraction of two replicates, and given for 
sequencing. Reads were mapped to the genome of T. brucei and the normalized read counts 
(reads per million, RPM) determined. The ratios between bound and unbound fractions were 
determined and those with ratios ≥2 are shown in table 1. 
Table 3: List of mRNA co-purified with PUF3 
GeneID Annotation Category Bound 
(B) 
average 
RPM 
Unbound 
(U) 
average 
RPM 
log2 
(B/U) 
Tb927.10.11280 Hypothetical protein, T 
brucei only 
Unknown 1.9 0.4 2.1 
Tb927.11.4440 Hypothetical protein Unknown 2.5 0.8 1.6 
Tb927.1.4210 Hypothetical protein Unlikely 1.7 0.7 1.3 
Tb927.11.16190 Ϯ Hypothetical protein Unknown 1.7 0.7 1.2 
Tb927.10.1790 Hypothetical protein Unknown 1.2 0.5 1.2 
Tb927.11.17690 ESAG3 pseudogene ESAG 
pseudo 
5.4 2.4 1.1 
Tb11.v5.0375 Ϯ Hypothetical protein, 
conserved 
Unknown 8.1 3.9 1.1 
Tb927.9.8910 Hypothetical protein Unlikely 1.2 0.5 1.1 
Tb927.11.12710 Ϯ Variant surface 
glycoprotein (VSG)-
related, putative 
VSG 5.3 2.5 1.1 
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Tb927.9.2610 Hypothetical protein Unlikely 4.5 2.1 1.1 
Tb927.1.2780 Ϯ Hypothetical protein Unknown 2.8 1.3 1.1 
Tb927.7.2660 Ϯ ZC3H20 RNA binding 76.8 35.4 1.1 
Tb927.1.3510 Hypothetical protein Unlikely 1.5 0.7 1 
Tb927.3.5780 Hypothetical protein Unknown 2.6 1.3 1 
Tb927.11.13140 Ϯ Cytochrome oxidase 
subunit X 
Mito electron 
transport 
20.2 10.1 1 
Tb927.9.14660 SLACS reverse 
transcriptase, putative 
Unknown 7.7 3.9 1 
Tb927.1.810 Hypothetical protein Unlikely 3.1 1.5 1 
Tb927.11.18660 Expression site-associated 
gene 9 
ESAG 1.7 0.9 1 
Tb927.1.940 Hypothetical protein Unlikely 1 0.5 1 
Tb927.1.2170 Hypothetical protein Unlikely 1.4 0.7 1 
Genes marked with “Ϯ” have annotated 3’UTRs and were used for motif searches. 
Generally, apart from ZC3H20, the genes had very low RPMs and according to our lab 
experience, such candidates are likely to be non-specific. Reverse transcription followed by 
PCR did not detect ZC3H20 or Tb927.10.11280 in the bound RNA. These two were chosen 
because ZC3H20 had most read representation while Tb927.10.11280 was the best bound 
candidate. Motif search on the 3’UTR of these genes did not yield any significant result. 
Variants of the consensus pumilio motif UGUANAUG 107 appeared in both bound and 
unbound genes. The high number of PUF proteins which supposedly share a consensus motif 
would make it difficult and biased to get a PUF3 motif judging only from the e-values. 
 
3.17 Protein partners of PUF3 
To determine the proteins that associate with PUF3 and therefore acquire a hint of how PUF3 
represses gene expression, a cell line expressing a fusion of TAP tag and PUF3 (pHD 2893, 
TAP-PUF3) from the endogenous locus was used for tandem affinity purification. The 
experiment was done in triplicate and the bound proteins analyzed by mass spectrometry. A 
control pull-down with GFP-TAP together with a list of common contaminants from previous 
analyses from our lab were used to obtain the list of possible targets (Table 4). For inclusion, 
a protein had to be absent in the GFP control and have less than three peptides in 59 
previous runs from our lab.  
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Table 4: List of proteins and number of peptides co-purified with PUF3 in triplicate 
GeneID Description rep1 rep2 rep3 
Tb927.10.310 PUF3 28 18 16 
Tb927.11.7510 Luminal binding protein 1 (BiP), putative 16 4 2 
Tb927.11.4100 Variant surface glycoprotein (VSG), 
putative 
6 3 1 
Tb927.11.4820 60S ribosomal protein L29 3 2 2 
Tb927.10.8980 Hypothetical protein, conserved 2 1 2 
 
PUF3 was successfully purified in all the replicates and was the most abundant protein. Other 
precipitated proteins were present in rather low amount and were likely non-specific based on 
experiences with previous pull-downs in our lab, and were therefore not pursued. This does 
not however mean that PUF3 does not bind any proteins. Instead, interactions with PUF3 
could be unstable thus unsustainable throughout the two-step long procedure of TAP 
purification. Transient interactions are also conceivable and would not be detected by this 
procedure. However, technical challenges could also be a reason for the fewer number of 
peptides detected in replicate 2 and 3 as compared to replicate 1. 
 
3.18 Targets of PUF3 identified by RNA editing 
As an alternative method to identify RNA targets of PUF3, I used a method called TRIBE 
(Targets of RNA Identified By Editing) 159. It exploits the Drosophila ADAR catalytic domain 
(adenosine deaminase acting on RNA), which deaminates adenosine (A) to inosine (I). This 
mutation is detected as guanosine (G) by ribosomes and RNAseq 159. Native ADAR consists 
of an N-terminus double-stranded RNA-binding domain and a C-terminus catalytic domain. I 
expressed a fusion between the ADAR catalytic domain (henceforth simply referred to as 
ADAR) and PUF3 from the endogenous locus of PUF3 (Figure 21A). PUF3 would therefore 
direct editing by ADAR, which marks PUF3 targets with irreversible A>I mutations 
approximately within 500 bp 159 from PUF3 binding site, and targets are identified by RNAseq 
and bioinformatics. ADAR however, has a preference for adenosines flanked by 5’ uridine and 
3’ guanosine in a double-stranded RNA sequence and lacks processivity, and as a result may 
lead to failure to identify some RBP targets 177. 
With the premise that PUF3 regulates gene expression during differentiation to stumpy (Figure 
19BC), cells were treated for 36hrs with 10µM of a hydrolysable cAMP analog (8-pCPT-2’-O-
Me-cAMP) which induces stumpy formation 33–35, and their RNA sequenced. An alternative 
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would have been to grow the cells to high densities in methyl cellulose containing media, but 
this method never gave intact RNA in a previous experiment (see Figure 8C). Edited sites 
were detected as in the original description of TRIBE 159 and as described in the methods 
section. A>G mutations were defined as loci with A>80% and G=0% in genomic DNA and 
G>0% in RNA. For genes in the reverse strand, the reverse complement T>C was evaluated. 
The following threshold - used in the original description of TRIBE - was also used here i.e. 
loci with alignment depth < 20 and with < 10% edited residues (edited bases/total bases) were 
discarded as endogenous editing sites. Edited loci were compared against identical loci from a 
control cell line expressing ADAR-GFP fusion. PUF3 with ADAR on its C-terminus was also 
included because it was hypothesized from KO complementation studies (Figure 15) that C-
terminal tags inactivate PUF3, and would therefore act as an additional control (Figure 21A). 
All the fusion proteins used were knockins into the PUF3 locus with the other PUF3 allele 
deleted. 
 
3.18.1 Editing by ADAR is directed by an RNA binding domain 
I first looked at the raw data before removing sites that had not meet the editing threshold i.e. 
sites with depth <20 and editing events <10%. I included TRIBE datasets from Drosophila 
(details in the methods) for comparison, and examined all possible mutations in addition to 
A>G (Figure 21B). In both Trypanosoma and Drosophila, the number of A>G edited sites were 
more in samples expressing ADAR compared to those lacking ADAR, indicating that ADAR is 
indeed responsible for the additional A>G mutations. ADAR-PUF3 had more A>G editing than 
in the GFP control (see aG vs aP, Figure 21B). C>G mutations were the least frequent in the 
two species but the most frequent varied. 
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Figure 21: Editing by ADAR catalytic domain is directed by an RNA binding PUF3. (A) Models 
of the fusions between ADAR catalytic domain (ADARctd) and PUF3/GFP. (B) Comparison of 
number of all detected edited sites for Drosophila and T. brucei. na; Non-ADAR, u; uninduced, 
i; induced, aG; ADAR-GFP, aP; ADAR-PUF3, Pa; PUF3-ADAR. (C) Number of edited sites in 
ADAR containing samples of T. brucei following filters in (B). The insert Venn diagram 
represents the overlap between ADAR containing samples. (D) Table shows the percentage 
editing events retained after filtering for depth and percentage editing. Alignment depths are 
average of all loci used in the alignment and were determined using samtools. (E) Principle 
component analysis of the samples in (C). The non-ADAR samples were slender forms while 
the ADAR samples were differentiated to stumpy forms. (F) Frequency of edited sites per 
gene. Tbru_na 1-4 represent the four T. brucei samples lacking ADAR in the same order 
shown in (A). 
On removing endogenous editing events from the A>G raw data of trypanosomes, more than 
80% of the editing events were discarded for lack of at least 10% editing and another 10% for 
lack of depth (Figure 21D). These samples had roughly the same alignment depth (Figure 
21D) thus excluding bias due to depth differences. ADAR-PUF3 had more than 5-times more 
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edited loci than the GFP control (Figure 21C) indicating that editing by ADAR is preferably 
directed by an RNA binding protein.  
As predicted earlier, PUF3 with a C-terminal fusion appears inactive; it might be expected to 
either direct ADAR editing similar to PUF3 with ADAR on the N terminus or be inactive. In fact, 
it had similar number of sites as the control cell-line. Furthermore, most of the A>G loci in the 
PUF3-ADAR cell line (120/209) were shared with the GFP control, 86 of which were common 
in all TRIBE samples and were probably ADAR biased sites (These are double stranded RNA 
sites that are preferentially edited by even ADAR lacking its dsRNA binding domain). In 
addition, PUF3-ADAR and ADAR-GFP also cluster together in a principle component analysis 
plot (Figure 21E). It may be argued that in the PUF3-ADAR cell-line, it was ADAR which was 
inactive and not PUF3 because of tagging its N-terminus. However, the native ADAR in 
Drosophila is preceded by an RNA-binding domain at its N-terminus therefore an N-terminal 
tag would not inactivate ADAR 159,178. ADAR on PUF3 C-terminal end could compromise RNA 
binding because PUF3 pumilio domains are in the C-terminus (Figure 13) and the addition of 
~50kDa ADAR-fusion on the distal end may sterically impair access to RNA, resulting in non-
specific editing. This cell-line was henceforth used as a control together with GFP-ADAR. 
PUF3-ADAR and ADAR-GFP cell lines could essentially be considered as PUF3 knockout 
cells since they have no functional PUF3. The lack of association between ADAR-PUF3 cells 
with the controls in the PCA plot (Figure 21E) is suggestive of a difference in the 
transcriptomes. However, differential expression analysis could not be done because that 
would need replicates.  
Edited sites were mapped to genes models using ANNOVAR 162 and the number of editing per 
gene determined (Figure 21E). I identified 295 genes in the ADAR-PUF3 sample which are 
six-times more than the TRIBE controls (GFP-ADAR and PUF3-ADAR). This increase in the 
number of genes identified indicates that editing by ADAR is faithfully directed by the RNA-
binding protein. This would assume that PUF3-ADAR is defective in binding RNA resulting to 
its similarities with the GFP control. Most of the genes were edited on a single loci consistent 
with ADAR’s lack of processivity and similar to TRIBE in Drosophila 159. 
Overall, the results indicate high RNA editing/mutations across cells even in the absence of 
ADAR. However, more edited sites on RNA were observed in the sample that contained a 
functional RNA binding domain (ADAR-PUF3) and less in samples expressing ADAR that 
lacked an RNA binding capability (GFP-ADAR or PUF3-ADAR). Figure 22 shows examples of 
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screenshots of select sites for PUF3-TRIBE in Trypanosomes and Hrp48-TRIBE in 
Drosophila. 
 
Figure 22: Example screenshots of edited sites in PUF3-TRIBE in Trypanosoma and Hrp48-
TRIBE in Drosophila. Horizontal grey bars represent RNA reads aligned to genes with 
mismatches shown by nucleotide letters. A>G mutations were detected in the forward strand 
and T>C mutations in the reverse strand. The name of the sample is indicated on the left of 
the reads. Inducible Hrp48-ADAR was used in Hrp48-TRIBE in Drosophila and the Wild-type 
sample lacked the TRIBE construct. The datasets are described in the methods section. 
 
3.18.2 Putative targets of PUF3 identified by TRIBE 
To obtain target genes of PUF3, all the A>G edited loci from the control cells and from those 
lacking ADAR were subtracted from the ADAR-PUF3 list to obtain 295 possible targets. These 
genes were clustered in functional categories (Figure 23). The majority of the genes were of 
unknown function, followed by cytoskeleton, protein kinases, RNA binding, leucine rich repeat 
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proteins (LRRP), expression-site associated genes (ESAG), chaperones and translation. 
Retrotransposons have high mutation rates and always detected in SNP calling, so were 
considered as false targets 159. 
 
Figure 23: Putative targets of PUF3. (A) Functional categories of putative PUF3 targets. 
Categories with less than 1% representation were clustered together under ‘Others’ for 
demonstration purposes. (B) Number of categories of genes unique to three ADAR samples. 
(C) Numbers of developmentally regulated targets. These are genes that are more than 2-fold 
regulated in slender bloodstream, procyclic or stumpy forms. 
Out of the 295 putative PUF3 target genes, 43% encode proteins of unknown function (Figure 
23A). Interesting categories include cytoskeleton proteins (8%), protein kinases (4%) and 
RNA binding proteins (3%), mitochondria pathways (2%), since these are likely to be involved 
in differentiation 45. In addition, ADAR-PUF3 had more unique gene categories than both 
controls (Figure 23B). 
PUF3 is predicted to participate in developmental regulation and its targets would therefore be 
regulated between different forms and during differentiation. Genes that are regulated at least 
2-fold between bloodstream and procyclic forms 45 and those that are regulated during stumpy 
formation 179 were matched with the list of ADAR-PUF3 targets. Interestingly, 79 of these were 
enriched in bloodstream forms consistent with PUF3 role as a repressor during differentiation. 
However, dominance of bloodstream expressed genes can arguably be circumstantial 
because the morphology of cAMP treated cells is not entirely stumpy and remnant slender 
bloodstream cells exist. Further cAMP treated cells are “unhealthy” 35 and this could explain 
the high number of cytoskeleton related genes. Nevertheless, having bloodstream enriched 
genes as targets is consistent with a role of PUF3 as a repressor of bloodstream-type mRNAs 
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during differentiation to stumpy forms. These targets include the repressors RBP10, DRBD5 
and a conserved hypothetical protein. High confidence genes edited more than once are listed 
in Table 5. 
 
Table 5: List of mRNA edited more than once by ADAR-PUF3 
Gene ID Annotation #edits Region Category 
Tb927.3.720 ZFP3 2 3’UTR;3’UTR RNA binding 
Tb927.10.1540 ZC3H30 2 3’UTR;3’UTR RNA binding 
Tb927.10.13490 serine/threonine kinase, putative 2 3’UTR;3’UTR Protein kinase 
Tb927.8.6260 hypothetical protein, conserved 2 Exonic; Exonic Unknown 
Tb927.8.4500 eIF4G5 3 3’UTR;3’UTR;3’UTR Translation 
Tb927.8.3690 Isocitrate dehydrogenase [NADP], 
mitochondrial precursor (IDH) 
2 3’UTR;3’UTR Citric acid cycle 
Tb927.8.3250 IAD-1beta inner arm dynein heavy 
chain 
2 Exonic; Exonic Cytoskeleton 
Tb927.4.360 1,2-Dihydroxy-3-keto-5-
methylthiopentene dioxygenase, 
putative 
2 3’UTR;5’UTR Amino acids 
Tb927.9.11050 4EIP, 4E-interacting protein 2 3’UTR;5’UTR Translation 
Tb927.11.5850 RBP38 2 3’UTR;exonic RNA binding 
Tb927.11.7570 ATP-grasp domain containing 
protein, putative 
2 3’UTR;exonic Unknown 
Tb927.11.15240 Ras-related protein RAB2B, 
putative 
2 3’UTR;3’UTR Vesicular 
transport 
Tb927.5.3790 Tetraspanin family, putative 2 3’UTR;exonic Unknown 
Tb927.7.350 hypothetical protein 2 Exonic; Exonic Unknown 
Tb927.7.3580 NEK11 protein kinase 3 3’UTR;3’UTR Protein kinase 
Tb927.6.4800 Hypothetical protein, conserved, 
tetratricopeptide repeat domain 
2 Exonic; Exonic Unknown 
 
There was no overlap between PUF3 RNA-immunoprecipitation (PUF3-RIP) and PUF3-
TRIBE. An overlap was not however expected because slender cells were used in PUF3-RIP 
and stumpy cells for PUF3-TRIBE. The use of TRIBE enabled the study of PUF3 in stumpy 
cells where RNA immunoprecipitation would otherwise be extremely challenging. 
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A high number of protein kinases and RNA binding proteins (RBPs) were identified among the 
target mRNA products. These might be involved in perception of the differentiation signal and 
the subsequent signaling pathway. Protein kinases and RBPs however, have long 3’UTRs 
and have more chances of getting edited. To check whether there was bias of length in the 
genes edited, I compared the lengths of 3’UTR and coding sequence (CDS) of the ADAR 
targets verses all trypanosome genes. Because of the differences in numbers of targets in 
each sample (Figure 21D), I assumed non-parametric test - Kruskal Wallis statistics. In all 
cases, the lengths of CDS and 3’UTRs of ADAR-PUF3 edited genes were longer compared to 
all trypanosome genes (Figure 24A and B) (adjusted P<0.0001). In addition, PUF3-ADAR 
edited genes had longer 3’UTRs. Since lengths of GFP-ADAR edited genes were not different 
from the total genes, the length differences observed here were characteristic of PUF3 and 
not ADAR. 
 
Figure 24: Characteristics of ADAR edited genes. (A) Box and whiskers plot comparing 
lengths of coding sequences (CDS) of ADAR-PUF3, ADAR-GFP and PUF3-ADAR with 
lengths of all genes using one-way ANOVA and Kruskal Wallis test. Boxes represent the 
upper quartile, median and lower quartile, while whiskers represent the 5 and 95 percentiles. 
(****) indicate significance at adjusted p<0.0001, ns; not significant, (*) indicate significance at 
adjusted p=0.04. (B) Similar parameters as in (A) to compare lengths of 3’UTRs. (C) Similar 
comparison as in (B) between lengths of CRP (cytoskeleton, RBP and protein kinases genes), 
non-CRP and all genes with lengths of all CRP. (D) Number of sites in each 3’UTR, coding 
sequence (CDS) and 5’UTR of edited genes. In all cases, only genes with annotated 3’UTR 
were considered. 
In the categories of ADAR-PUF3 targets, cytoskeleton, RBP and protein kinases genes (here 
collectively abbreviated to CRP) are the most represented and in addition, are known to have 
long 3’UTRs. To determine whether CRP dominate the long 3’UTRs in the targets, I compared 
3’UTR lengths of CRP, non-CRP and all genes against all CRP in the genome using the same 
statistics as before. CRPs had longer 3’UTR lengths as expected but their lengths were not 
different from other non-CRP targets, further confirming that longer 3’UTR targets are a 
dominant character of ADAR-PUF3 (Figure 24C). 
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RBPs affect their targets by mostly binding elements in the 3’UTR, though there are also 
examples of CDS targeting 77. Using 2-way ANOVA and Turkey’s multiple comparison test, I 
examined whether there was a preference for editing by recombinant ADAR in the 5’UTR, 
CDS or 3’UTR. There was no significant difference (P<0.05) between editing frequency in any 
region. ADAR-PUF3 had more sites in the CDS followed by the 3’UTR but these differences 
were not significant when regions were compared to each other within samples. There was 
equally no significant difference in the number of edited region between samples. 
Motif searches were performed on the 295 ADAR-PUF3 targets using the GFP-ADAR targets 
as controls in DREME 155. 1000 nucleotides upstream and downstream of the edited sites 
were used as input sequences. Edited sites in TRIBE are found within 500 nucleotides of the 
RBP-binding site 159. No motifs were detected with an e-values <0.05 and none was detected 
using 3’UTRs of all targets, bloodstream enriched targets or the most abundant gene 
categories.  
These targets could however not be validated by RNA immunoprecipitation because cells 
treated with cAMP analogs are unhealthy and it would not be viable to obtain intact RNA 
following lengthy immunoprecipitation procedures. This had already been predicted from 
efforts to obtain intact RNA from stumpy forms (Figure 8C). In addition, large amounts of 
cAMP analog would be required for such an experiments and was therefore not an 
economically viable choice. 
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4.0 Discussion 
 
4.1 4E-interacting protein represses expression during differentiation 
The initiation steps of translation offer multiple opportunities for control. Mechanisms range 
from the use of eIF4E-like cap binding proteins that do not recruit eIF4G 119,141,180,181, to use of 
4E-binding proteins (4EBPs) that compete with eIF4G for binding eIF4E 125,140. The genomic 
potential to encode multiple eIF4Gs, eIF4E, eIF4E-like and 4EBPs enables segmentation of 
general translation into fractions that enables dedicated translation of a subset of mRNAs in 
response to stress conditions and during development. Trypanosomes and related 
kinetoplastids have two hosts – a mammal (homoeothermic) and an invertebrate insect 
(poikilothermic). While inside their hosts, trypanosomes survive various stresses including 
immune and nutritional, and as they move from one body compartment to another, they 
exhibit pleomorphism, a manifest of their robust gene regulation mechanisms. Consistently, 
they encode a relatively high number of translation initiation factors; six eIF4Es, five eIF4Gs 
and two eIF4A which have potential for multiple eIF4F-like complexes. In addition, they 
encode a novel kinetoplastid-conserved 4E-binding protein, 4E-interacting protein (Tb4EIP) 
which was the focus of this work. 
The results show that Tb4EIP is a repressor of gene expression independent of TbEIF4E1. 
Tethering of TbEIF4E1 in the absence of Tb4EIP had no effect on a reporter mRNA, 
suggesting repression by TbEIF4E1 is dependent on Tb4EIP. These results are similar to 
those of mammalian GIGYF2 and 4E-T, which functions independent of 4EHP 141,142, and 
Drosophila Cup which functions independent of eIF4E 135. GIGYF2 binds to mammalian 4EHP 
and is recruited to a subset of mRNA by various RNA binding proteins, including zinc finger 
protein ZNF598 116 and tristetraprolin (TTP) 117,118. Immunoprecipitation of Tb4EIP did not 
identify possible ligand that would suggest recruitment to particular mRNAs, but identified 
TbEIF4E1 as the only reproducible binding partner 152. However, yeast-2 hybrid assay 
identified the zinc finger protein ZC3H14 as a possible ligand of Tb4EIP 152. However, 
ZC3H14 was not identified as an activator/repressor of gene expression in a tethering screen 
84 and does not seem to bind RNA according to a poly(A) mRNA-bound proteome 78. In fact, 
there is no evidence that ZC3H14 is expressed in the forms available in culture (TriTrypDB), 
and it may therefore be active in other parasite forms. Tb4EIP protein partners other than 
TbEIF4E1 therefore remain to be identified. 
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According to the tethering results, TbEIF4E1 is not a repressor and is unlikely to promote 
translation. These result should however be read with caution because of the artificial nature 
of the mRNA-protein interaction in a tethering assay. TbEIF4E1 was tethered by its N-
terminus to the 3’UTR of a reporter mRNA and it may not necessarily bind the mRNA cap in 
that state. In addition its cap binding affinity which is already 3 times worse than TbEIF4E4/3 
148 may be further lowered on tethering. The alternative interpretation therefore is that 
TbEIF4E1 is a repressor in the absence of Tb4EIP by merely occupying the cap, an effect that 
tethering may not report. However, the flexibility of mRNA could facilitate proximity and 
binding between the 3’UTR-tethered TbEIF4E1 and the mRNA cap. Tethering of proteins to 
the 5’UTR is not possible since this would prevent movement of the translation pre-initiation 
complex. It is therefore still not known whether TbEIF4E1 is a functional translation 
factor/repressor, or whether it is only relevant in the presence of Tb4EIP. 
TbEIF4E1 could be a translation factor if it were to bind TbEIF3 like in Leishmania. 
Leishmania LmEIF4E1 was found to interact with other translation factors including subunits 
of eIF2 and eIF3 in promastigotes 150. In addition, the protein levels of LmEIF4E1 were 
unchanged during heat shock (this induces differentiation to amastigotes) and in amastigotes, 
while those of LmEIF4E4 and LmEIF4G3 decreased in amastigotes. Together, it was 
predicted that LmEIF4E1 could be a translation factor in amastigotes where Lm4EIP 
interaction is lacking 150. A similar mechanism could therefore be speculated in trypanosomes 
where binding of Tb4EIP would prevent binding of eIF3 and dislodge TbEIF4E1 from the 
mRNA cap to suppress translation. Functions of Leishmania and Trypanosoma 4EIP may 
however be different because they are regulated differently in different life stages 150. 
Another possible mechanism could assume that TbEIF4E1 is a repressor and binding of 
Tb4EIP to TbEIF4E1 would free the cap and then enable a translationally active eIF4E to 
initiate translation. This would be consistent with a proposed model in Leishmania where 
binding of Lm4EIP decreased cap binding affinity of LmEIF4E1 151. This however depicts 
Tb4EIP as a passive translational repressor and ignores its repressive role independent of 
TbEIF4E1. 
Tb4EIP could also act independent of TbEIF4E1 to repress expression. It is not known where 
Tb4EIP binds its target mRNA and what its RNA binding domain is. The glutamine-proline rich 
C-terminus could facilitate RNA binding by ionic interactions. If it were to bind the 5’UTR, then 
Tb4EIP-TbEIF4E1 complex could spatially block binding of a translationally active eIF4E or 
block scanning by the pre-initiation complex hence repress translation. However, the tethering 
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assay also showed that Tb4EIP is a repressor of mRNA, suggesting recruitment of mRNA 
degradation machineries in addition to repressing translation. 
Tb4EIP interaction partners identified by tandem affinity purification (TAP) and yeast two 
hybrid screens could not be validated by co-immunoprecipitation with the exception of 
TbEIF4E1. In addition to TAP purification, a single-step myc pull-down was done (by 
colleagues) and identified the terminal uridylyl transferase TUT3. I was able to validate the 
Tb4EIP and TUT3 interaction by co-immunoprecipitation. The amount co-purified even in the 
reciprocal pull-down was small suggesting that the interaction was very weak (Figure 6). This 
could be the reason why TUT3 was undetectable in the two-step TAP purifications. This result 
highlights the existence of weak interactions that are undetectable by standard two-step 
immunoprecipitation experiments that are often missed resulting in false negative results. 
TUT3 function is unknown. It has been shown to catalyze uridylation in vitro 170. Uridylated 
GPEET mRNA has been detected in early procyclic forms and is absent in late procyclic forms 
168, consistent with the exclusive expression of GPEET in early procyclic forms. This 
uridylation could facilitate GPEET mRNA degradation similar to mammalian TUT4/7, which 
uridylate mRNA with short poly(A) tails, marking them for deadenylation/ decapping and 
degradation 167. Uridylation could therefore be a signal for mRNA degradation in 
trypanosomes. Since TUT3 is neither a repressor nor an activator of expression (according to 
a genome-wide tethering screen 84), and it does not bind poly(A) mRNA 78, it is conceivable 
that Tb4EIP recruits TUT3 to mRNA for uridylation that is followed by degradation. Uridylation 
by TUT3 could therefore form one of the mechanisms of Tb4EIP. TUT3 tethering experiment 
and in vivo studies on the effects of uridylation are needed to strengthen or disqualify this 
hypothesis. To test this hypothesis, the fate of GPEET mRNA could be analyzed in Tb4EIP 
KO cells, assuming that TUT3 is responsible for GPEET uridylation in early procyclic forms. 
The inability of Tb4EIP to repress expression in TUT3 KO would certainly support such a 
hypothesis. 
Tb4EIP is not essential in bloodstream or procyclic forms but is required during transformation 
from the former to the latter. Activity of Tb4EIP however may not be exclusive during 
differentiation as growing cells experienced a mild growth defect (Figure 7). As recently shown 
together with my colleagues, Tb4EIP in growing bloodstream cells binds to unstable mRNAs 
that have low ribosome occupancy 152; this points to a function in fine-tuning the transcriptome 
besides its role in differentiation. This function may however be dispensable because upon 
prolonged culture, cells lacking Tb4EIP seem to adapt and recover normal growth (Figure 7). 
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Nevertheless, Tb4EIP mutants were unable to repress translation during stumpy formation 
and this generated defective cells that could not differentiate to viable procyclic cells (Figure 
8). In addition, over-expression of Tb4EIP increased longevity at high cell densities and 
speeded the expression of the stumpy marker PAD1, suggesting a protective role of Tb4EIP 
in stumpy forms.  Leishmania Lm4EIP is also thought to be involved in stage-specific 
functions as it is expressed mainly in the insect stage promastigote forms 150. Its interaction 
with LmEIF4E1 is also restricted to promastigotes contrary to trypanosome Tb4EIP whose 
interaction with TbEIF4E1 is present in growing forms of both mammals and insects (Figure 
4). 
 
4.2 PUF3 is required for normal differentiation 
PUF3 was identified as a strong repressor in a genome-wide tethering screen and in a 
subsequent tethering screen of a mini-ORFeome 78,84. It is conserved among trypanosomatids, 
has similar domain organization as its orthologs and is likely to have similar function to its 
orthologs. PUF proteins are generally involved in cell differentiation and organelle biogenesis 
107, and they act by repressing mRNA stability or translation.  
The results here suggest that PUF3 is required for normal differentiation. Knockout mutants 
exhibited a short delay in expression of differentiation markers PAD1, EP and GPEET. This 
defect was demonstrated in pleomorphic cells under PUF3 RNAi conditions but was 
conspicuously absent in PUF3 knockout pleomorphic cells. It could be argued that PUF3 RNAi 
was indiscriminate and would target other PUF mRNAs resulting in the observed defect. 
However, the defect was reproduced in monomorphic cells with PUF3 knocked-out. In 
addition, the defect was rescued by adding back PUF3 to the knockouts therefore 
demonstrating that the defect was as a result of PUF3 deficiency. A similar phenotype has 
been reported in cells depleted of ZC3H18 96. In contrast to PUF3, the phenotype in ZC3H18 
depleted pleomorphic cells was short-lived – detectable only up to 12 hours after induction of 
differentiation, and PAD1 expression was unaffected. The role of ZC3H18 in differentiation is 
unknown. ZC3H18, PUF3 and Tb4EIP represent a class of genes which are dispensable in 
growing cells but are specifically required in differentiation. These RNA binding proteins likely 
fine-tune the transcriptome/proteome in readiness for differentiation. 
Putative protein partners of PUF3 could not be confidently identified using tandem affinity 
purifications. The identified ones were mostly ubiquitous proteins or proteins unrelated to 
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PUF3 role as a repressor. This could possibly be due to a general challenge to recover 
unstable degradation-associated complexes as compared to recovering stable ones: 
assembly of degradation machinery lead to rapid destruction of mRNA-protein complexes 
while stabilizing complexes persist to protect mRNA and these are more likely to be detected. 
Examples of other RBPs for which no RNA decay proteins could be identified using TAP 
purification included repressors such as RBP10 45 and 4EIP 152. On the other hand, stabilizing 
complexes involving MKT1 91 were readily found. Some abundant targets e.g. translation 
factors could be falsely discarded as contaminants. This challenge could extend to identifying 
mRNA targets of repressors by RNA immunoprecipitation due to the rapid loss of targets. 
Initial experiments on growth kinetics in pleomorphic bloodstream cells showed that PUF3 
depletion by RNAi caused a slight growth defect, while PUF3 knockout did not. This could be 
attributed to an adaptation mechanism to life without PUF3 similar to that observed in 
pleomorphic bloodstream cells lacking Tb4EIP. Add-back of PUF3 similarly had no effect on 
the growth of pleomorphic bloodstream cells lacking PUF3. Interestingly, a growth defect was 
observed on forced expression of PUF3 add-back during differentiation to procyclic forms and 
further in late procyclic forms. The add-back gene was intended to be over-expressed, though 
this could not be verified for lack of an anti-PUF3 antibody and useful tagging options. Over-
expression of PUF5 was also shown to impair growth of procyclic but not bloodstream cells, 
and the authors attributed this defect to disrupted gene regulation by non-specific binding of 
the excess PUF5 101. In addition, over-expression of ZC3H12 or ZC3H13 was also toxic in 
procyclic cells 94. Over-expression in T. brucei has however been used in library screens and 
other applications with acceptable successes 35,45,84,173,182. In a recent study, expression of 
RBP6 to form epimastigotes subsequently increased PUF5 transcripts. This would be 
consistent with the over-expression results of PUF5 that disrupts growth of procyclic forms – 
PUF5 could be involved in epimastigote biology. Since over-expression of PUF3 in 
bloodstream forms caused no growth defect (Figure 16), the defect observed in procyclic 
forms could not be entirely dismissed as non-specific. Procyclic forms lacking PUF3 showed a 
slight growth defect while no effect on cell growth was observed by PUF3 over-expression in 
bloodstream forms. These results suggest that PUF3 levels could be tightly regulated below 
some quota in procyclic forms. 
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4.3 Identifying targets of RBP using TRIBE 
The standard method to identify targets of RNA binding proteins is by cross-linking followed by 
immunoprecipitation (CLIP) 183,184. There are numerous variants of CLIP which improve 
various steps of the original method including cross-linking, cell lysis, RNA fragmentation, 
purification of protein-RNA complexes, RNA extraction and library preparations 185. For 
example, in PAR-CLIP (Photoactivatable ribonucleoside-enhanced CLIP), cells are pre-
incubated with 4-thiouridine (4SU) or 6-thioguanosine (6SG), which crosslink to bound protein 
when irradiated at a specific longer wavelength of 365 nm instead of 254 nm. This method has 
the highest resolution to date. However, longer incubation with the nucleosides can be toxic to 
cells, and RNA with many U and G residues would be preferentially crosslinked. Generally, 
CLIP requires a large amount of starting material which can be limited in the case of 
trypanosomes, which are approximately 100 times smaller than mammalian cells, and in most 
experiments cannot be grown to very high densities. The whole CLIP procedure is extremely 
lengthy and also has a bias of identifying long and highly expressed genes 186. 
TRIBE (Targets of RNA-binding proteins Identified by Editing) is a method that could 
overcome many CLIP constraints. Targets of RNA binding proteins are permanently marked 
with novel RNA editing events that can be identified by Ranse and bioinformatics. The method 
does not require an antibody: it involves cloning of a fusion between ADAR (adenosine 
deaminase acting on RNA) and an RNA binding protein, standard library preparation and 
RNAseq, thus only a small amount of starting material is needed. This is especially useful in 
differentiation studies since many cells do not complete the differentiation process in vitro thus 
limiting the RNA yield as already seen in dense cells (Figure 8C). In terms of media required 
for cell growth, an RNA-immunoprecipitation experiment would need 3-6 litres whereas 20-50 
ml are enough for TRIBE.  
Using TRIBE, mRNA targets of PUF3 in cells treated with 10µM cAMP analog (8-pCPT-2’-O-
Me-cAMP) were identified, the majority of which were enriched in slender bloodstream forms, 
consistent with PUF3 as a repressor of bloodstream genes during differentiation. However, 
because the cAMP analog generates cells that are not fully stumpy (stumpy-like) 35, this could 
result in a slender-bloodstream biased transcriptome. Nevertheless, a principle component 
analysis did not cluster the cAMP treated cells with slender bloodstream cells (Figure 21E). 
There was no overlap between RNA-immunoprecipitation (RIP) and PUF3-TRIBE targets, 
perhaps because different parasite forms were used in each of the experiments. In addition, 
the pull-down in the RIP was not reliable, evidenced by the few reads that represented 
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precipitated RNAs, and the failure to detect the best candidates by RT-PCR. Further, no 
motifs were detected in the TRIBE targets, but this was also seen with Tb4EIP suggesting that 
other factors apart from the sequence could be involved in binding e.g. secondary structures 
or cooperation with other RBPs. However, the increased number of gene targets relative to 
the controls indicates that the TRIBE targets are not random but result from PUF3 directed 
editing. 
The ADAR catalytic domain has also been exploited in other editing contexts where guide 
RNAs are used to direct precise editing of particular bases in RNA by ADAR 187. Another 
setup involves RNA tagging, where an RBP is fused to C. elegans poly(U) polymerase, which 
adds U-tails on RNA. However, this method requires special library preparation procedures. In 
contrast, TRIBE follows standard library preparation procedures 159. However, TRIBE too has 
some limitations including a false negative problem because ADAR has a preference for 
editing sites in double stranded regions even in the absence of its double-stranded RNA 
binding domain. In particular, it has a preference for an adenosine flanked by a 5’ uridine and 
a 3’ guanosine (UAG) in a double stranded RNA, and lacks processivity. This was evidenced 
by the many genes identified with only one edited site (Figure 21F). However, an improvement 
of TRIBE called HyperTRIBE has recently been used with promising outcomes 177. 
HyperTRIBE uses an E488Q mutant of ADAR which has reduced specificity i.e. a hyperactive 
ADAR that catalyzes more edit events per binding site 177. HyperTRIBE identified more targets 
and had a higher overlap with CLIP data indicating a reduced false-negative. I have embarked 
on using HyperTRIBE in trypanosomes. To enable subsequent validation, I use RBP10 and 
ZC3H11 whose targets are published, and in addition, PUF2 as a test protein. If successful, 
this method could be applied to other RBPs and enable venturing into novel stage-specific 
targets with unprecedented sensitivity. 
 
5.0 Conclusion 
The complex life cycle of trypanosomes requires robust mechanisms that modulate gene 
expression as the parasite differentiates and is transmitted from one host to another. In 
addition to ZFP1, ZFP2, ZFP3, ZC3H18, RBP10 and RBP6, PUF3 and 4EIP include the list of 
RNA binding proteins that modulate differentiation. PUF3 and 4EIP are both repressors of 
gene expression and possibly involved in fine-tuning the transcriptome/proteome of 
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differentiating cells. The role of PUF3 however appears dispensable as pleomorphic cells 
seem to adapt to life without it. 
The results from PUF3-TRIBE depict a specific editing pattern by ADAR directed by PUF3. If 
validated, this method would open limitless horizons to easily identify targets of RBPs in 
trypanosomes. 
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